US20220330857A1 - Apparatus and method for imaging blood in a target region of tissue - Google Patents

Apparatus and method for imaging blood in a target region of tissue Download PDF

Info

Publication number
US20220330857A1
US20220330857A1 US17/739,916 US202217739916A US2022330857A1 US 20220330857 A1 US20220330857 A1 US 20220330857A1 US 202217739916 A US202217739916 A US 202217739916A US 2022330857 A1 US2022330857 A1 US 2022330857A1
Authority
US
United States
Prior art keywords
light
spectral range
tissue
target region
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US17/739,916
Inventor
Scott Grubb
Allan Kenneth Frazer Grugeon Hunt
Peter Laitenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew PLC
Original Assignee
Smith and Nephew PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1703771.4A external-priority patent/GB201703771D0/en
Priority claimed from GBGB1703772.2A external-priority patent/GB201703772D0/en
Application filed by Smith and Nephew PLC filed Critical Smith and Nephew PLC
Priority to US17/739,916 priority Critical patent/US20220330857A1/en
Publication of US20220330857A1 publication Critical patent/US20220330857A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14558Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters by polarisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4887Locating particular structures in or on the body
    • A61B5/489Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898Portable consumer electronic devices, e.g. music players, telephones, tablet computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0431Portable apparatus, e.g. comprising a handle or case
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04Arrangements of multiple sensors of the same type
    • A61B2562/046Arrangements of multiple sensors of the same type in a matrix array
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03BAPPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B15/00Special procedures for taking photographs; Apparatus therefor
    • G03B15/02Illuminating scene
    • G03B15/03Combinations of cameras with lighting apparatus; Flash units
    • G03B15/05Combinations of cameras with electronic flash apparatus; Electronic flash units
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30101Blood vessel; Artery; Vein; Vascular
    • G06T2207/30104Vascular flow; Blood flow; Perfusion

Definitions

  • This disclosure relates to apparatus for imaging blood within a target region of tissue and a corresponding method of imaging blood within a target region of tissue.
  • Wound healing is natural process performed by the human body in response to injury.
  • the amount of time taken for a wound to heal is dependent on many different factors which include the human body's ability to heal itself and any treatments that are applied to the wound to accelerate wound healing. Understanding the healing status of a wound and being able to monitor the healing process helps to inform decisions on further treatment of the wound and can also assist in the development of future wound therapies.
  • One factor that is known to be associated with wound healing is the amount of blood supplied to blood vessels within tissue at or near a wound.
  • the process of supplying blood to blood vessels within tissue is known as blood perfusion.
  • Oxygen and nutrients carried by blood within wounded tissue are essential for wound healing and so the amount of oxygenated blood within tissue is known to correlate well with wound healing.
  • Conventional techniques for determining the presence of blood within skin tissue include near-infrared imaging to determine oxygen saturation of blood vessels within tissue at or near a wound.
  • apparatus for imaging blood within a target region of tissue comprising: an imaging device configured to output image data associated with light received by the imaging device having a first spectral range and configured to output image data associated with light received by the imaging device having a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue.
  • the imaging device may comprise an imaging sensor comprising a plurality of sensor elements, wherein each sensing element is configured to output data associated with the amount of light received by the sensing element at the first spectral range and to output data associated with the amount of light received by the sensing element at the second spectral range.
  • the plurality of sensor elements may be arranged in a two-dimensional array.
  • the imaging sensor may comprise a digital imaging sensor.
  • the digital imaging sensor may comprise a complementary metal-oxide semiconductor image sensor or a charge-couple device imaging sensor.
  • the controlling element may be configured to record a first value associated with the amount of light received by each sensing element at the first spectral range and a second value associated with the amount of light received by each sensing element at the second spectral range.
  • the controlling element may be further configured to generate a compound value associated with each sensing element based on the first value and the second value.
  • the compound value may be a difference between the first value and the second value.
  • the controlling element may be configured to apply a scaling factor to the first value and/or second value when generating the compound value.
  • the apparatus may further comprise a digital display unit, wherein the controlling element is configured to display a digital image comprising a plurality of pixels on the display, wherein each pixel is associated with at least one of the sensing elements and each pixel has a value based on the compound value associated with each respective sensing element.
  • the controlling element is configured to display a digital image comprising a plurality of pixels on the display, wherein each pixel is associated with at least one of the sensing elements and each pixel has a value based on the compound value associated with each respective sensing element.
  • the digital image may have a predefined brightness and/or colour scale based on which the compound values for each sensing element are represented.
  • the first spectral range may correspond to a spectral range associated with red light.
  • the second spectral range may correspond to a spectral range associated with green light.
  • the apparatus may further comprise a light source configured to provide illuminating light having the first spectral range and to provide illuminating light having the second spectral range.
  • the light source may be configured to provide illuminating light having a spectral range which encompasses the first spectral range and the second spectral range.
  • the light source may comprise at least one light emitting diode.
  • a method of imaging blood within a target region of tissue comprising the steps of: capturing image data associated with at least a portion of a target region of tissue at a first spectral range; capturing image data associated with at least the portion of a target region of tissue at a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue.
  • the step of capturing image data at the first spectral range and the step of capturing image data at the second spectral range may comprise capturing image data using an imaging sensor comprising a plurality of sensor elements to capture image data associated with the amount of light received by each sensing element at each of the first spectral range and the second spectral range.
  • the step of processing the image data captured at the first spectral range and the image data captured at the second spectral range may comprise the step of comparing a first value associated with the amount of light received by each sensing element at the first spectral range and a second value associated with the amount of light received by each sensing element at the second spectral range.
  • the step of processing the image data captured at the first spectral range and the image data captured at the second spectral range may comprise the step of generating a compound value associated with each sensing element based on the first value and the second value.
  • the compound value may be a difference between the first value and the second value.
  • the method may further comprise the step of applying a scaling factor to the first value and/or second value when generating the compound value.
  • the method may further comprise the step of at least one of displaying, storing and transmitting the compound image data for analysis.
  • the method may further comprise the step of generating digital image having a predefined brightness and/or colour scale based on which the compound values for each sensing element are represented.
  • the first spectral range may correspond to a spectral range associated with red light.
  • the second spectral range may correspond to a spectral range associated with green light.
  • the method may further comprise the step of illuminating the target region of tissue using a light source which provides illuminating light having first spectral range and the second spectral range.
  • the illuminating light may have a spectral range which encompasses the first spectral range and the second spectral range.
  • the light source may comprise at least one light emitting diode.
  • Certain embodiments of the present disclosure allow for images to be obtained of a target region of tissue that provide an indication of the amount and/or distribution and/or concentration of blood within the skin tissue. Certain embodiments of the present disclosure allow for images to be obtained using digital imaging sensors.
  • Certain embodiments of the present disclosure allow for images to be obtained using digital imaging sensors configured to produce image data having at least two components associated with different spectral ranges.
  • Certain embodiments of the present disclosure allow for images to be generated by combining image data having at least two components associated with different spectra ranges.
  • apparatus for imaging blood within a target region of tissue comprising: an imaging device configured to output image data associated with light received by the imaging device having a first spectral range and configured to output image data associated with light received by the imaging device having a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue, wherein the first spectral range corresponds to a spectral range associated with red light.
  • apparatus for imaging blood within a target region of tissue comprising: a light source configured to provide illuminating light having a first spectral range and to provide illuminating light having a second spectral range; an imaging device configured to output image data associated with light received by the imaging device having the first spectral range and configured to output image data associated with light received by the imaging device having the second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue.
  • a method of imaging blood within a target region of tissue comprising the steps of: capturing image data associated with at least a portion of a target region of tissue at a first spectral range; capturing image data associated with at least the portion of a target region of tissue at a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue, wherein the second spectral range corresponds to a spectral range associated with green light.
  • a method of imaging blood within a target region of tissue comprising the steps of: illuminating a target region of tissue using a light source which provides illuminating light having a first spectral range and a second spectral range, wherein the illuminating light has a spectral range which encompasses the first spectral range and the second spectral range; capturing image data associated with at least a portion of a target region of tissue at the first spectral range; capturing image data associated with at least the portion of a target region of tissue at the second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image
  • apparatus for imaging blood within a target region of tissue comprising: a light source configured to illuminate at least a portion of a target region of tissue with linearly polarised light having at least a first spectral range and a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; an imaging system having an imaging sensor configured to capture an image of at least a portion of the target region of tissue illuminated by the linearly polarised light; and a first linearly polarising filter arranged in front of the imaging device such that, in use, the polarising filter is disposed between the imaging device and the target region of tissue, wherein the first linearly polarising filter is arranged to block polarised illuminating light reflected by the target region of tissue.
  • the first linearly polarising filter may be arranged to polarise light in a plane which is orthogonal to the plane of polarisation of the illuminating light.
  • the light source may comprise a light emitter configured to emit unpolarised light and a second linearly polarising filter disposed in front of the light emitter.
  • the light emitter may comprise at least one light emitting diode.
  • the second linearly polarising filter may be arranged in a cross-polarised configuration with respect to the first polarising filter such that light polarised by the second linearly polarising filter which remains polarised after being reflected by the target region of skin tissue is blocked by the first linearly polarising filter.
  • the first and second linearly polarising filters may be arranged such that the plane of polarisation of the first linearly polarising filter is at an angle of 90 degrees to the plane of polarisation of the second linearly polarising filter.
  • the light source may be configured to illuminate the portion of the target region of tissue with visible light.
  • the first spectral range may correspond to a spectral range associated with red light and the second spectral range corresponds to a spectral range associated with green light.
  • the light source may comprise a diffuser arranged to provide diffused illuminating light.
  • the apparatus may be a smartphone.
  • a method of imaging blood within a target region of tissue comprising the steps: illuminating a target region of tissue using linearly polarised light having at least a first spectral range and a second spectral range, such that the linearly polarised light is scattered and/or reflected by the target region of tissue, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; arranging an imaging system comprising an imaging sensor such that the imaging sensor is arranged to receive light scattered and/or reflected by the target region of tissue; disposing a linearly polarising filter between the target region of tissue and the imaging sensor such that scattered light which has been depolarised by the target region of tissue is transmitted by the linearly polarising filter and reflected light which remains polarised is blocked by the linearly polarising filter; and using the imaging system to capture at least one image of at least a portion of the target region of tissue using light which
  • the linearly polarising filter may be arranged such that the plane of polarisation of the linearly polarising filter is orthogonal to the plane of polarisation of the illuminating light.
  • the step of illuminating a target region of tissue using linearly polarised light may comprise the step of using a light emitter configured to emit unpolarised light to emit light and disposing a second linearly polarising filter in front of the emitter to polarise the illuminating light.
  • the target region of tissue may be illuminated with visible light.
  • the visible light may comprise a first spectral range that corresponds to a spectral range associated with red light and a second spectral range that corresponds to a spectral range associated with green light.
  • the linearly polarised light may be diffused light.
  • a method of imaging blood within a target region of tissue comprising the steps: illuminating a target region of tissue using linearly polarised light having at least a first spectral range and a second spectral range, such that the linearly polarised light is scattered and/or reflected by the target region of tissue, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; transmitting by a linearly polarising filter disposed between the target region of tissue and the imaging sensor scattered light which has been depolarised by the target region of tissue and blocking by the linearly polarising filter reflected light which remains polarised; receiving with an imaging sensor light scattered and/or reflected by the target region of tissue; and capturing at least one image of at least a portion of the target region of tissue using light which has been transmitted by the linearly polarising filter.
  • the linearly polarising filter may be arranged such that the plane of polarisation of the linearly polarising filter is orthogonal to the plane of polarisation of the illuminating light.
  • the step of illuminating a target region of tissue using linearly polarised light may comprise the step of using a light emitter configured to emit unpolarised light to emit light and disposing a second linearly polarising filter in front of the emitter to polarise the illuminating light.
  • the target region of tissue may be illuminated with visible light.
  • the visible light may comprise a first spectral range that corresponds to a spectral range associated with red light and a second spectral range that corresponds to a spectral range associated with green light.
  • the linearly polarised light may be diffused light.
  • Certain embodiments of the present disclosure allow for images of blood within tissue to be obtained that are not adversely affected by light which is reflected by the tissue without penetrating the tissue.
  • FIG. 1 shows an imaging apparatus for imaging a target region of tissue
  • FIG. 2 is a schematic representation of key components of the imaging apparatus shown in FIG. 1 ;
  • FIG. 3 is a graphical illustration of spectral response curves for a sensor used in the apparatus shown in FIG. 1 ;
  • FIG. 4 is a flow chart of a method of imaging a target region of tissue using the apparatus shown in FIG. 1 ;
  • FIG. 5 is graphical illustration showing absorptivity of light by haemoglobin for different wavelengths
  • FIG. 6A is an illustrative example of an image generated by the apparatus shown in FIG. 1 ;
  • FIG. 6B is an illustrative example of a further image generated by the apparatus shown in FIG. 1 ;
  • FIG. 7 is a flow chart of further method of imaging a target region of tissue using the apparatus shown in FIG. 1 ;
  • FIG. 8A is an illustrative example of an image generated by the method shown in FIG. 7 ;
  • FIG. 8B is an illustrative example of a further image method generated by the method shown in FIG. 7 ;
  • FIG. 9 is a flow chart of a further method of imaging a target region of tissue using the apparatus shown in FIG. 1 ;
  • FIG. 10A is an illustrative example of an image generated using the method shown in FIG. 9 ;
  • FIG. 10B is an illustrative example of an image generated using the method shown in FIG. 9 ;
  • FIG. 100 is an illustrative example of an image generated using the method shown in FIG. 9 ;
  • FIG. 11 is a schematic presentation of apparatus for imaging a target region of skin tissue.
  • FIG. 12 is presentation of another apparatus for imaging a target region of skin tissue.
  • FIG. 1 shows an apparatus 2 for imaging blood vessels within a target region of tissue being used to investigate distribution of blood within tissue at the back of a portion of a person's hand 7 .
  • the apparatus 2 could, of course, be used to image other regions of a person's body or portions of an animal's body such as a region of a torso or a leg or an arm, for example.
  • the apparatus 2 comprises a support structure in the form of a support frame 4 having a base 6 on which the hand 7 is placed, walls 8 , 10 which extend upwardly from the base 6 and an equipment support platform 12 .
  • the support platform 12 extends horizontally from one wall 8 to the other wall 10 and is located above the base 6 and spaced away from the base 6 by a suitable distance. In the embodiment shown, the support platform 12 is spaced from the base 6 by 30 cm.
  • the support platform 12 may be spaced from the base 6 by between 5 cm and 100 cm, such as between 20 cm and 50 cm in accordance with requirements such as a requirement to keep a target region of tissue within a focal range of a camera module, as described below.
  • a light source 14 is secured to the support platform 12 and arranged to illuminate the back of the hand 7 placed on the base 6 below.
  • a camera module 16 is also secured to the support platform 12 and arranged to capture images of the back of the hand 7 placed on the base 6 below.
  • the support frame 4 therefore holds the light source 14 and the camera module 16 in a fixed special relationship with respect to each other and the base 6 .
  • a display unit 18 for processing and displaying images captured by the camera module 16 is secured to the support platform 12 .
  • the display unit 18 comprises a portable device having an integrated screen 20 .
  • the display unit 18 may be a tablet device, smart phone, laptop, computer or the like.
  • FIG. 2 is a schematic representation of components of the apparatus 2 shown in FIG. 1 .
  • Components of the display unit 18 are enclosed by broken lines.
  • the display unit 18 comprises a power source in the form of a battery 22 , a controller or processor 24 and an output device 26 which is configured to display an output from the processor 24 on the screen 20 of the display unit 8 .
  • the processor 24 is configured to control the light source 14 and to process image data from the camera module 16 .
  • other power sources may be used such as a mains power supply or the like.
  • the light source 14 is a high-intensity light source in the form of an LED torch.
  • the LED torch comprises a plurality of LEDs 15 which are configured to emit white light having a broad spectral range.
  • each LED may be configured to emit light having spectral range of wavelengths between 380 nm and 770 nm.
  • the camera module 16 comprises a digital imaging sensor 17 having a two-dimensional array of discrete sensing elements. Each sensing element is configured to produce an output having three separate components including: a component associated with the amount of red light received at the sensing element; a component associated with the amount of green light received at the sensing element; and a component associated with the amount of blue light received at the sensing element.
  • each sensing element comprises three separate identical sensors.
  • Each sensing element has a respective filter configured to transmit light within a predefined spectral range associated with one of red, green and blue light respectively.
  • the digital imaging sensor is a complementary metal-oxide semiconductor (CMOS) digital imaging sensor.
  • CMOS complementary metal-oxide semiconductor
  • the sensor is a SonyTM IMX219 sensor configured to produce image data for generating a 3296 by 2512 pixel image.
  • the spectral response curves for each of the component outputs of the digital imaging sensor 17 is shown in FIG. 3 .
  • the spectral response curve associated with the amount of blue light received at each sensing element is shown by response curve B.
  • the response curve has a peak response for blue light within the spectral range 400 nm and 500 nm.
  • the spectral response curve associated with the amount of green light received at each sensing element is shown by response curve G.
  • the response curve has a peak response for green light within the spectral range 520 nm and 580 nm.
  • the spectral response curve associated with the amount of red light received at the sensing element is shown by response curve R.
  • the response curve has a peak response for red light within the spectral range 590 nm and 750 nm.
  • the imaging sensor 17 is therefore configured to produce output components associated with the amount of blue, green and red light received at each sensing element which can be processed to generate an image comprising an array of pixels in which each pixel is associated with a respective sensor element. Images can therefore be produced in which each pixel has a blue, green or red value that corresponds to the amount of blue, green and red light received at each sensing element.
  • Other sensors having suitable response curves such as a charge coupled devices (CCD) or the like could of course be utilised.
  • FIG. 4 A flow chart illustrating a method of imaging blood within a target region of tissue in order to determine the distribution of blood within the tissue is shown in FIG. 4 .
  • a hand 7 is placed with the palm facing upward on the base 6 of the support frame 4 below the light source 14 and the camera module 16 .
  • the light source 14 is activated by the processor 24 to illuminate the region of the hand 7 in view of the camera module 16 .
  • the camera module 16 is controlled by the processor 24 to produce image data associated with a target region of tissue of the hand 7 which is within view of the camera module 16 and illuminated by the light source 14 .
  • the digital imaging sensor 17 of the camera module 16 is controlled to produce image data for each of the sensing elements forming the array of sensing elements.
  • the image data for each sensing element has blue, green and red components, as described above.
  • the processor 24 determines a value for each of the blue, green and red components based on the received image data.
  • the processor 24 generates a red value I R and a green value I G and a blue value I B for each sensing element.
  • the red value I R is associated with the amount of red light received by the sensing element.
  • the green value I G is associated with the amount of green light received by the same sensing element.
  • the blue value I B is associated with the amount of blue light received by the same sensing element.
  • the values are then used to generate a visual digital image and a compound digital image of the target region of tissue.
  • the step of generating a visual digital image is optional.
  • Each image comprises an array of pixels in which the location of each pixel corresponds to the location of a corresponding sensing element of the imaging sensor 17 .
  • the processor 24 generates the visual digital image, as shown in FIG. 6A , using all three components to produce an image corresponding to that which is seen by the naked eye.
  • the image is displayed on the screen 20 of the display unit 18 by the output device 26 .
  • the first image allows the target region of tissue to be inspected by a clinician to determine that the hand 7 is positioned correctly and that there are no anomalies that may affect analysis.
  • the processor 24 In order to generate the compound digital image, the processor 24 generates a compound value I C for each sensing element which corresponds to a respective pixel of the compound digital image.
  • a compound value I C for each pixel is generated by subtracting the green value I G from the red value I R .
  • a scaling factor ‘a’ is applied to the green value I G .
  • the value of ‘a’ may also set in accordance with other subjective factors related to representation and interpretation of the second image.
  • the value of ‘a’ may be in the range 0.01 to 100, such as in the range 0.1 to 10 and may be in the range 1 to 5, such as 1.
  • the compound value I C is therefore calculated as follows:
  • the magnitude of the compound value I C provides an indication of the local distribution of blood within the target region of tissue associated with the pixel. This is because haemoglobin within blood absorbs green light much better than red light and so the amount of green light received at a sensing element is heavily dependent on the amount of blood within skin tissue whereas the amount of red light received at a sensing element is not.
  • FIG. 5 shows the spectral absorption by haemoglobin and haemoglobin species of light having wavelengths between 450 nm and 750 nm (as described at http://www.derangedphysiology.com/main/core-topics-intensive-care/arterial-blood-gas-interpretation/Chapter %203.0.1/absorption-spectroscopy-haemoglobin-species, which is incorporated herein by reference in its entirety).
  • haemoglobin and the species oxygenated haemoglobin absorb more green light corresponding to the spectral range of the response curve G than they absorb red light corresponding to the spectral range of the response curve R. Consequently, the amount of green light absorbed at the target region of tissue is highly dependent on the amount of blood within the tissue. Conversely, the amount of red light absorbed at the target region of tissue has a much lower dependency on the amount of blood within the tissue.
  • the green value I G for each pixel is proportional to the amount of green light detected by the imaging sensor 17 and so is inversely proportional to the amount of light absorbed. Therefore, a low green value I G , and by implication a high compound value I C , is associated with a large amount of blood within the region of tissue. The compound value I C therefore provides a reliable indicator of the amount of blood within tissue depicted by an associated pixel in the compound image.
  • the skin tissue itself absorbs green and red light having spectral ranges corresponding to those shown in FIG. 3 substantially equally and so the value of I C is relatively unaffected by the nature of the skin tissue surrounding blood vessels.
  • the compound value I C is converted for each pixel using a suitable scale, for example, based on brightness and/or a colour range to produce the second image, as shown in FIG. 6B .
  • Areas having a greater amount (higher concentration) of blood within the tissue i.e. comprising pixels having a relatively high I C-HIGH value
  • areas having a lesser amount (lower concentration) of blood within the tissue i.e. comprising pixels having a relatively low I C-LOW value
  • contour lines within the image are delineated by contour lines within the image.
  • spectral ranges associated with high and low amounts of absorptivity by haemoglobin and oxygenated haemoglobin are utilised in the present embodiment to evaluate the concentration of blood within tissue, other spectral ranges could be selected in addition to, or as an alternative, that correspond to high and low amounts of absorptivity for other compounds that may be found within tissue and other compounds that may be found within blood.
  • the light source 14 is configured to emit light having at least one wavelength, or range of wavelengths, which is both well absorbed by blood and which falls within the range of the response curve of the imaging sensor 17 associated with green light and at least one wavelength, or range of wavelengths, which is less well absorbed by blood and which falls within the range of the response curve of the imaging sensor 17 associated with red light.
  • FIG. 7 shows a flow chart illustrating a further method of using the apparatus 2 shown in FIG. 1 to monitor changes in blood perfusion within skin tissue.
  • the apparatus 2 is used in conjunction with a restriction device in the form of an inflatable cuff (not shown) such as an Omron M3 Comfort Automatic Upper Arm Blood Pressure Monitor.
  • the inflatable cuff is wrapped around a person's upper arm of the hand that is to be inspected.
  • a hand is placed on the base 6 of the apparatus 2 .
  • the light source 14 is activated to illuminate a target region of tissue of the hand.
  • a first compound image is generated using components of the output of the camera module 16 as described above in connection with the process step S 1030 .
  • a visual image may also be generated, as described in step S 1030 . However, such a step is optional and omitted in this instance.
  • a first compound image is stored, transmitted or displayed on the integrated display unit 18 .
  • FIG. 8A shows a first compound image in which the hand is relatively well perfused.
  • a scale having bands I C0 , I C1 , I C2 , I C3 , I C4 for different I C values is used to distinguish between areas having lowest I C values I C0 (i.e. low blood concentration) and areas having highest I C values I C4 (i.e. high blood concentration). Areas in which high and low concentrations of blood are present are therefore easy to identify within the image.
  • the inflatable cuff is inflated in order to restrict blood flow to the target region of tissue.
  • the target region is illuminated again at step S 2060 , image data is captured by the camera module 16 and a second compound image is generated at step S 2070 .
  • the suitable period of time may be at least 1 second or at least 2 seconds or at least 5 seconds.
  • the light source 14 may be deactivated between capture of the first and second compound images or else remain activated throughout steps S 2020 to S 2060 .
  • FIG. 8B shows a second compound image in which the hand 7 is poorly perfused following restriction by the inflatable cuff. There are, therefore, relatively few areas of the image in which indicate that high concentrations of blood are present in the target region of tissue.
  • the highest compound value I C in this image is I C4 compared with I C4 in the first image which indicates that much lower concentrations of blood are present.
  • Comparison of first and second compound images enables a qualitative assessment of blood perfusion to the target region of tissue. For example, if the inflation pressure of the cuff is known, the amount of blood perfusion in the second compound image in comparison the first compound image may be used to determine whether blood flow to the tissue is within normal bounds.
  • restriction of blood flow to the target region of tissue may be done by a tourniquet or pressing against a vessel supplying blood to the tissue or by pressing against the target region of tissue itself.
  • FIG. 9 shows a variation of the method shown in FIG. 7 .
  • steps S 3010 to S 3050 which are the same as steps S 2010 to S 2050 , a first compound image of a target region of tissue is obtained.
  • An example of a first compound image is shown in FIG. 10A .
  • the target region of tissue is illuminated and image data is captured such that at step S 3070 , at least two consecutive compound images of the target region of tissue are captured after the cuff has been inflated.
  • the consecutive images are stored, displayed or transmitted at step S 3080 for analysis.
  • the consecutive images are compared to determine whether the flow of blood within the target region has stabilised.
  • the consecutive images may be compared visually by a clinician or automatically using image analysis software. If blood flow has not stabilised, steps S 3060 to S 3090 are repeated until it is determined that flow of blood within the target region of tissue is stable.
  • An example of a compound image of the target region of tissue after it has been determined that the flow of blood within the tissue has stabilise is shown in FIG. 10B .
  • step S 3100 the time t 1 at which blood flow has stabilised is recorded and the restriction removed immediately at step S 3110 by deflation of the cuff.
  • Steps S 3120 to S 3140 (which correspond to steps S 3020 to S 3040 ) are then followed to obtain a further compound image of the target region of tissue.
  • step S 3150 the further compound image is compared against the first compound image to determine whether the distribution of blood within the tissue at the target region, and hence the flow of blood within the tissue, has returned/recovered to the original state prior to restriction of the blood flow. The comparison may once again be made visually by a clinician or automatically using suitable image analysis software. If distribution of blood has not returned to the original state, steps S 3120 to S 3150 are repeated.
  • the time t 2 at which it does so is recorded.
  • An example of a compound image obtained showing the distribution of blood within the target region of tissue once it has returned to its original state is shown in FIG. 100 .
  • suitable parameters such as a proportion of the pixels of the compound image having a compound value I C which is within a predetermined percentage of the first compound image or a return to an average I C value for a selection of pixels of the image may be sufficient to determine that the distribution of blood has returned to the original state.
  • the difference between time t 2 and time t 1 can then be calculated to determine a recovery time t R that provides an indication of the quality of blood perfusion at the target region.
  • a variant of the method shown in FIG. 9 has steps S 3060 to S 3100 omitted. Instead, a predetermined period of time is allowed to lapsed after inflation of the cuff which is sufficient to assume that blood flow has stabilised. The target region can then be imaged once the blood flow is known to have stabilised.
  • FIG. 11 shows a variation of the apparatus shown in FIG. 1 further comprising first and second linear polarising filters 28 , 30 .
  • the first linear polarising filter 28 mounted in front of the camera module 16 and the second linear polarising filter 30 is mounted in front of the light source 14 so that light emitted by the light source 14 is polarised before reaching the target region of tissue of the hand 7 and light reflected by the tissue towards the camera module 16 is polarised before it reaches the camera module 16 .
  • the first and second linear polarising filters are 28 , 30 are arranged in a cross-polarised configuration so that light polarised by the second linear polarising filter 30 which has not been de-polarised before reaching the first linear polarising filter 28 will be blocked by the first linear polarising filter 28 and so prevented from reaching the imaging sensor 17 in the camera module 16 .
  • the polarising plane of the first linear polarising filter 28 is at 90 degrees to the polarising plane of the second linear polarising filter 30 .
  • the first and second linear polarising filters 28 , 30 are set up in a cross-polarised configuration by placing a piece of flat aluminium foil (not shown) on the base 6 in the region at which the hand 7 is placed.
  • the light source 14 is then used to illuminate the aluminium foil and images are captured of the illuminated portion of the aluminium foil.
  • the first linear polarising filter 28 is then rotated with respect to the second linear polarising filter 30 until the light intensity of the captured images is at a minimum. At this orientation, the two polarising filters 28 , 30 are considered to be in a cross-polarised configuration.
  • a dedicated light source may be unnecessary since ambient light may be sufficient.
  • Camera modules comprising CCD or CMOS imaging sensors have been described with respect to the embodiments above.
  • Other imaging sensors may be used that are suitable for detecting the spectral content of light and producing a digital image comprising a plurality of pixels in which each pixel can have a value that corresponds a spectral content of light received by the sensor at a corresponding portion of the sensor.
  • Other imaging sensors having other suitable response curves may also be used.
  • Image data or images generated using image data can be processed or post-processed to enhance features of interest.
  • the brightness of images can be adjusted or contrast enhanced or colour adjusted or noise filter techniques or the like can be applied.
  • Other imaging processing techniques may be used to highlight features of interest within the images.
  • Light emitting diodes or a single diode may be used in accordance with the embodiments described above.
  • Surface mounted diodes which are compact, widely available, inexpensive, reliable, produce high-intensity light, have lower power consumption and are easy to integrate, may be used.
  • Other light sources such as lasers, laser diodes, digital light projectors (DLPs), organic light emitting diodes (OLED) or incandescent light sources or the like may be used.
  • the light source may be a broad-band or white light source such as the light source used in the embodiments described above, but may be a light source capable of illuminating the target region at two or more wavelengths, such as two monochromatic light sources, two laser diodes of different wavelengths, a multi-coloured LED or the like.
  • Two light sources may be used, neither of which has an emission spectra extending over a region of overlap of response curves for the imaging sensor in which there is a significant response for each response curve.
  • the spectral range of one light source may be different from the spectral range of the other light source. For example, red and green LEDs could be used as respective light sources.
  • An imaging sensor could be used which does not discriminate between the two spectral ranges and the light sources may be sequentially pulsed (i.e. activated and deactivated alternately) in order to obtain images at each of the respective spectral ranges.
  • Diffuser of lens arrangements may be used to provide a reasonably uniform illumination across a region of interest or to focus light on particular areas of interest.
  • the light source, camera module and display unit may be incorporated into a portable hand-held device having a single housing in which the components are housed.
  • a hand-held digital camera unit having an integrated flash unit could be configured to generate images in accordance with the imaging methods described above.
  • the portable hand-held device can be a smartphone, tablet, or the like with an integrated camera and a flash.
  • the hand-held device can be a smartphone 1200 .
  • the camera can be utilised to capture one or more images or videos.
  • one or more images can be captured using standard, burst capture, such as IPHONETM live photo capture. Capturing one or more images or videos can permit processing of the differential in absorption substantially in real time or offline.
  • One or more polarising filters can be positioned over the flash.
  • the flash can be turned on for the duration of the image or video capture.
  • An orthogonal polarising filter (whose polarising plane can be at 90 degrees to polarising plane(s) of the one or more filters positioned over the flash as described herein) can be positioned over an image lens of the camera.
  • the one or more filters positioned over the flash and the orthogonal filter positioned over the image lens are connected to be in cross-polarised configuration as described herein.
  • the one or more filters positioned over the flash can be tinted to prioritise only the frequencies of interest as described herein.
  • a lens such as macro lens 1210
  • a separate illumination source can be used.
  • Eulerian amplification techniques can be used in the analysis, as described in U.S. Provisional Patent Application Nos. 62/506,524, filed May 15, 2017 and 62/506,551, filed May 15, 2017, each of which is incorporated herein by reference in its entirety.
  • Eulerian magnification can, for example, amplify variations in absorption due to the pulse providing bursts of blood.
  • wound is to be broadly construed and encompasses open and closed wounds in which skin is torn, cut or punctured or where trauma causes a contusion, or any other superficial or other conditions or imperfections on the skin of a patient or otherwise that benefit from reduced pressure treatment.
  • a wound is thus broadly defined as any damaged region of tissue where fluid may or may not be produced.
  • wounds include, but are not limited to, abdominal wounds or other large or incisional wounds, either as a result of surgery, trauma, sternotomies, fasciotomies, or other conditions, dehisced wounds, acute wounds, chronic wounds, subacute and dehisced wounds, traumatic wounds, flaps and skin grafts, lacerations, abrasions, contusions, burns, diabetic ulcers, pressure ulcers, stoma, surgical wounds, trauma and venous ulcers or the like.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Vascular Medicine (AREA)
  • Multimedia (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

In some embodiments, an apparatus for imaging blood within a target region of tissue includes an imaging device configured to output image data associated with light received by the imaging device having a first and second spectral ranges, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, and a controlling element configured to capture the image data associated with light received by the imaging device and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue.

Description

  • This disclosure relates to apparatus for imaging blood within a target region of tissue and a corresponding method of imaging blood within a target region of tissue.
  • Wound healing is natural process performed by the human body in response to injury. The amount of time taken for a wound to heal is dependent on many different factors which include the human body's ability to heal itself and any treatments that are applied to the wound to accelerate wound healing. Understanding the healing status of a wound and being able to monitor the healing process helps to inform decisions on further treatment of the wound and can also assist in the development of future wound therapies.
  • One factor that is known to be associated with wound healing is the amount of blood supplied to blood vessels within tissue at or near a wound. The process of supplying blood to blood vessels within tissue is known as blood perfusion. Oxygen and nutrients carried by blood within wounded tissue are essential for wound healing and so the amount of oxygenated blood within tissue is known to correlate well with wound healing. Conventional techniques for determining the presence of blood within skin tissue include near-infrared imaging to determine oxygen saturation of blood vessels within tissue at or near a wound.
  • Typically, such techniques require specialised equipment that is both bulky and expensive. Techniques for imaging blood within tissue can be hampered by reflection of illuminating light by the upper surface of the tissue.
  • It is an aim of the present disclosure to at least partly mitigate the above-mentioned problems.
  • It is an aim of certain embodiments of the present disclosure to provide a means for imaging blood within tissue that can utilise a light source that provides illumination using visible light having a broad spectral range.
  • It is an aim of certain embodiments of the present disclosure to mitigate the effect of illuminating light which does not penetrate tissue on images obtained of blood within the tissue.
  • It is an aim of certain embodiments of the present disclosure to provide a means for imaging blood within tissue such that blood perfusion within the tissue can be assessed.
  • According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: an imaging device configured to output image data associated with light received by the imaging device having a first spectral range and configured to output image data associated with light received by the imaging device having a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue.
  • The imaging device may comprise an imaging sensor comprising a plurality of sensor elements, wherein each sensing element is configured to output data associated with the amount of light received by the sensing element at the first spectral range and to output data associated with the amount of light received by the sensing element at the second spectral range.
  • The plurality of sensor elements may be arranged in a two-dimensional array. The imaging sensor may comprise a digital imaging sensor. The digital imaging sensor may comprise a complementary metal-oxide semiconductor image sensor or a charge-couple device imaging sensor.
  • The controlling element may be configured to record a first value associated with the amount of light received by each sensing element at the first spectral range and a second value associated with the amount of light received by each sensing element at the second spectral range.
  • The controlling element may be further configured to generate a compound value associated with each sensing element based on the first value and the second value. The compound value may be a difference between the first value and the second value. The controlling element may be configured to apply a scaling factor to the first value and/or second value when generating the compound value.
  • The apparatus may further comprise a digital display unit, wherein the controlling element is configured to display a digital image comprising a plurality of pixels on the display, wherein each pixel is associated with at least one of the sensing elements and each pixel has a value based on the compound value associated with each respective sensing element.
  • The digital image may have a predefined brightness and/or colour scale based on which the compound values for each sensing element are represented.
  • The first spectral range may correspond to a spectral range associated with red light. The second spectral range may correspond to a spectral range associated with green light.
  • The apparatus may further comprise a light source configured to provide illuminating light having the first spectral range and to provide illuminating light having the second spectral range.
  • The light source may be configured to provide illuminating light having a spectral range which encompasses the first spectral range and the second spectral range. The light source may comprise at least one light emitting diode.
  • According to some embodiments, there is provided a method of imaging blood within a target region of tissue comprising the steps of: capturing image data associated with at least a portion of a target region of tissue at a first spectral range; capturing image data associated with at least the portion of a target region of tissue at a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue.
  • The step of capturing image data at the first spectral range and the step of capturing image data at the second spectral range may comprise capturing image data using an imaging sensor comprising a plurality of sensor elements to capture image data associated with the amount of light received by each sensing element at each of the first spectral range and the second spectral range.
  • The step of processing the image data captured at the first spectral range and the image data captured at the second spectral range may comprise the step of comparing a first value associated with the amount of light received by each sensing element at the first spectral range and a second value associated with the amount of light received by each sensing element at the second spectral range.
  • The step of processing the image data captured at the first spectral range and the image data captured at the second spectral range may comprise the step of generating a compound value associated with each sensing element based on the first value and the second value. The compound value may be a difference between the first value and the second value.
  • The method may further comprise the step of applying a scaling factor to the first value and/or second value when generating the compound value.
  • The method may further comprise the step of at least one of displaying, storing and transmitting the compound image data for analysis.
  • The method may further comprise the step of generating digital image having a predefined brightness and/or colour scale based on which the compound values for each sensing element are represented.
  • The first spectral range may correspond to a spectral range associated with red light. The second spectral range may correspond to a spectral range associated with green light.
  • The method may further comprise the step of illuminating the target region of tissue using a light source which provides illuminating light having first spectral range and the second spectral range. The illuminating light may have a spectral range which encompasses the first spectral range and the second spectral range. The light source may comprise at least one light emitting diode.
  • Certain embodiments of the present disclosure allow for images to be obtained of a target region of tissue that provide an indication of the amount and/or distribution and/or concentration of blood within the skin tissue. Certain embodiments of the present disclosure allow for images to be obtained using digital imaging sensors.
  • Certain embodiments of the present disclosure allow for images to be obtained using digital imaging sensors configured to produce image data having at least two components associated with different spectral ranges.
  • Certain embodiments of the present disclosure allow for images to be generated by combining image data having at least two components associated with different spectra ranges.
  • According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: an imaging device configured to output image data associated with light received by the imaging device having a first spectral range and configured to output image data associated with light received by the imaging device having a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue, wherein the first spectral range corresponds to a spectral range associated with red light.
  • According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: a light source configured to provide illuminating light having a first spectral range and to provide illuminating light having a second spectral range; an imaging device configured to output image data associated with light received by the imaging device having the first spectral range and configured to output image data associated with light received by the imaging device having the second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; and a controller or controlling element configured to capture the image data associated with light received by the imaging device having the first spectral range and image data associated with light received by the imaging device having the second spectral range contemporaneously and to process the captured image data associated with light having the first spectral range and the captured image data associated with light having the second spectral range to generate compound image data associated with an amount of blood within the target region of tissue.
  • According to some embodiments, there is provided a method of imaging blood within a target region of tissue comprising the steps of: capturing image data associated with at least a portion of a target region of tissue at a first spectral range; capturing image data associated with at least the portion of a target region of tissue at a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue, wherein the second spectral range corresponds to a spectral range associated with green light.
  • According to some embodiments, there is provided a method of imaging blood within a target region of tissue comprising the steps of: illuminating a target region of tissue using a light source which provides illuminating light having a first spectral range and a second spectral range, wherein the illuminating light has a spectral range which encompasses the first spectral range and the second spectral range; capturing image data associated with at least a portion of a target region of tissue at the first spectral range; capturing image data associated with at least the portion of a target region of tissue at the second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range, wherein the image data associated with at least a portion of a target region of tissue at a first spectral range and the image data associated with at least the portion of a target region of tissue at a second spectral range are captured contemporaneously; and processing the image data captured at the first spectral range and the image data captured at the second spectral range to generate compound image data associated with an amount of blood within the target tissue.
  • According to some embodiments, there is provided apparatus for imaging blood within a target region of tissue, comprising: a light source configured to illuminate at least a portion of a target region of tissue with linearly polarised light having at least a first spectral range and a second spectral range, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; an imaging system having an imaging sensor configured to capture an image of at least a portion of the target region of tissue illuminated by the linearly polarised light; and a first linearly polarising filter arranged in front of the imaging device such that, in use, the polarising filter is disposed between the imaging device and the target region of tissue, wherein the first linearly polarising filter is arranged to block polarised illuminating light reflected by the target region of tissue.
  • The first linearly polarising filter may be arranged to polarise light in a plane which is orthogonal to the plane of polarisation of the illuminating light.
  • The light source may comprise a light emitter configured to emit unpolarised light and a second linearly polarising filter disposed in front of the light emitter. The light emitter may comprise at least one light emitting diode.
  • The second linearly polarising filter may be arranged in a cross-polarised configuration with respect to the first polarising filter such that light polarised by the second linearly polarising filter which remains polarised after being reflected by the target region of skin tissue is blocked by the first linearly polarising filter.
  • The first and second linearly polarising filters may be arranged such that the plane of polarisation of the first linearly polarising filter is at an angle of 90 degrees to the plane of polarisation of the second linearly polarising filter. The light source may be configured to illuminate the portion of the target region of tissue with visible light.
  • The first spectral range may correspond to a spectral range associated with red light and the second spectral range corresponds to a spectral range associated with green light.
  • The light source may comprise a diffuser arranged to provide diffused illuminating light.
  • The apparatus may be a smartphone.
  • According to some embodiments, there is provided a method of imaging blood within a target region of tissue, comprising the steps: illuminating a target region of tissue using linearly polarised light having at least a first spectral range and a second spectral range, such that the linearly polarised light is scattered and/or reflected by the target region of tissue, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; arranging an imaging system comprising an imaging sensor such that the imaging sensor is arranged to receive light scattered and/or reflected by the target region of tissue; disposing a linearly polarising filter between the target region of tissue and the imaging sensor such that scattered light which has been depolarised by the target region of tissue is transmitted by the linearly polarising filter and reflected light which remains polarised is blocked by the linearly polarising filter; and using the imaging system to capture at least one image of at least a portion of the target region of tissue using light which has been transmitted by the linearly polarising filter.
  • The linearly polarising filter may be arranged such that the plane of polarisation of the linearly polarising filter is orthogonal to the plane of polarisation of the illuminating light.
  • The step of illuminating a target region of tissue using linearly polarised light may comprise the step of using a light emitter configured to emit unpolarised light to emit light and disposing a second linearly polarising filter in front of the emitter to polarise the illuminating light. The target region of tissue may be illuminated with visible light.
  • The visible light may comprise a first spectral range that corresponds to a spectral range associated with red light and a second spectral range that corresponds to a spectral range associated with green light. The linearly polarised light may be diffused light.
  • According to some embodiments, there is provided a method of imaging blood within a target region of tissue, comprising the steps: illuminating a target region of tissue using linearly polarised light having at least a first spectral range and a second spectral range, such that the linearly polarised light is scattered and/or reflected by the target region of tissue, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range; transmitting by a linearly polarising filter disposed between the target region of tissue and the imaging sensor scattered light which has been depolarised by the target region of tissue and blocking by the linearly polarising filter reflected light which remains polarised; receiving with an imaging sensor light scattered and/or reflected by the target region of tissue; and capturing at least one image of at least a portion of the target region of tissue using light which has been transmitted by the linearly polarising filter.
  • The linearly polarising filter may be arranged such that the plane of polarisation of the linearly polarising filter is orthogonal to the plane of polarisation of the illuminating light.
  • The step of illuminating a target region of tissue using linearly polarised light may comprise the step of using a light emitter configured to emit unpolarised light to emit light and disposing a second linearly polarising filter in front of the emitter to polarise the illuminating light. The target region of tissue may be illuminated with visible light.
  • The visible light may comprise a first spectral range that corresponds to a spectral range associated with red light and a second spectral range that corresponds to a spectral range associated with green light. The linearly polarised light may be diffused light.
  • Certain embodiments of the present disclosure allow for images of blood within tissue to be obtained that are not adversely affected by light which is reflected by the tissue without penetrating the tissue.
  • Embodiments of the present disclosure will now be described, by way of example only, with reference to the accompanying drawings in which:
  • FIG. 1 shows an imaging apparatus for imaging a target region of tissue;
  • FIG. 2 is a schematic representation of key components of the imaging apparatus shown in FIG. 1;
  • FIG. 3 is a graphical illustration of spectral response curves for a sensor used in the apparatus shown in FIG. 1;
  • FIG. 4 is a flow chart of a method of imaging a target region of tissue using the apparatus shown in FIG. 1;
  • FIG. 5 is graphical illustration showing absorptivity of light by haemoglobin for different wavelengths;
  • FIG. 6A is an illustrative example of an image generated by the apparatus shown in FIG. 1;
  • FIG. 6B is an illustrative example of a further image generated by the apparatus shown in FIG. 1;
  • FIG. 7 is a flow chart of further method of imaging a target region of tissue using the apparatus shown in FIG. 1;
  • FIG. 8A is an illustrative example of an image generated by the method shown in FIG. 7;
  • FIG. 8B is an illustrative example of a further image method generated by the method shown in FIG. 7;
  • FIG. 9 is a flow chart of a further method of imaging a target region of tissue using the apparatus shown in FIG. 1;
  • FIG. 10A is an illustrative example of an image generated using the method shown in FIG. 9;
  • FIG. 10B is an illustrative example of an image generated using the method shown in FIG. 9;
  • FIG. 100 is an illustrative example of an image generated using the method shown in FIG. 9;
  • FIG. 11 is a schematic presentation of apparatus for imaging a target region of skin tissue; and
  • FIG. 12 is presentation of another apparatus for imaging a target region of skin tissue.
  • FIG. 1 shows an apparatus 2 for imaging blood vessels within a target region of tissue being used to investigate distribution of blood within tissue at the back of a portion of a person's hand 7. The apparatus 2 could, of course, be used to image other regions of a person's body or portions of an animal's body such as a region of a torso or a leg or an arm, for example.
  • The apparatus 2 comprises a support structure in the form of a support frame 4 having a base 6 on which the hand 7 is placed, walls 8, 10 which extend upwardly from the base 6 and an equipment support platform 12. The support platform 12 extends horizontally from one wall 8 to the other wall 10 and is located above the base 6 and spaced away from the base 6 by a suitable distance. In the embodiment shown, the support platform 12 is spaced from the base 6 by 30 cm. The support platform 12 may be spaced from the base 6 by between 5 cm and 100 cm, such as between 20 cm and 50 cm in accordance with requirements such as a requirement to keep a target region of tissue within a focal range of a camera module, as described below.
  • A light source 14 is secured to the support platform 12 and arranged to illuminate the back of the hand 7 placed on the base 6 below. A camera module 16 is also secured to the support platform 12 and arranged to capture images of the back of the hand 7 placed on the base 6 below. The support frame 4 therefore holds the light source 14 and the camera module 16 in a fixed special relationship with respect to each other and the base 6. A display unit 18 for processing and displaying images captured by the camera module 16 is secured to the support platform 12. In the embodiment show, the display unit 18 comprises a portable device having an integrated screen 20. The display unit 18 may be a tablet device, smart phone, laptop, computer or the like.
  • FIG. 2 is a schematic representation of components of the apparatus 2 shown in FIG. 1. Components of the display unit 18 are enclosed by broken lines. The display unit 18 comprises a power source in the form of a battery 22, a controller or processor 24 and an output device 26 which is configured to display an output from the processor 24 on the screen 20 of the display unit 8. The processor 24 is configured to control the light source 14 and to process image data from the camera module 16. In other embodiments, other power sources may be used such as a mains power supply or the like.
  • In the embodiment shown, the light source 14 is a high-intensity light source in the form of an LED torch. The LED torch comprises a plurality of LEDs 15 which are configured to emit white light having a broad spectral range. For example, each LED may be configured to emit light having spectral range of wavelengths between 380 nm and 770 nm.
  • The camera module 16 comprises a digital imaging sensor 17 having a two-dimensional array of discrete sensing elements. Each sensing element is configured to produce an output having three separate components including: a component associated with the amount of red light received at the sensing element; a component associated with the amount of green light received at the sensing element; and a component associated with the amount of blue light received at the sensing element.
  • In the embodiment shown, each sensing element comprises three separate identical sensors. Each sensing element has a respective filter configured to transmit light within a predefined spectral range associated with one of red, green and blue light respectively.
  • Such digital imaging sensors are commonly used in the field of digital photography. In the embodiment shown, the digital imaging sensor is a complementary metal-oxide semiconductor (CMOS) digital imaging sensor. The sensor is a Sony™ IMX219 sensor configured to produce image data for generating a 3296 by 2512 pixel image.
  • The spectral response curves for each of the component outputs of the digital imaging sensor 17 is shown in FIG. 3.
  • The spectral response curve associated with the amount of blue light received at each sensing element is shown by response curve B. The response curve has a peak response for blue light within the spectral range 400 nm and 500 nm. The spectral response curve associated with the amount of green light received at each sensing element is shown by response curve G. The response curve has a peak response for green light within the spectral range 520 nm and 580 nm. The spectral response curve associated with the amount of red light received at the sensing element is shown by response curve R. The response curve has a peak response for red light within the spectral range 590 nm and 750 nm.
  • The imaging sensor 17 is therefore configured to produce output components associated with the amount of blue, green and red light received at each sensing element which can be processed to generate an image comprising an array of pixels in which each pixel is associated with a respective sensor element. Images can therefore be produced in which each pixel has a blue, green or red value that corresponds to the amount of blue, green and red light received at each sensing element. Other sensors having suitable response curves such as a charge coupled devices (CCD) or the like could of course be utilised.
  • A flow chart illustrating a method of imaging blood within a target region of tissue in order to determine the distribution of blood within the tissue is shown in FIG. 4.
  • At step S1010, a hand 7 is placed with the palm facing upward on the base 6 of the support frame 4 below the light source 14 and the camera module 16.
  • At step S1020, the light source 14 is activated by the processor 24 to illuminate the region of the hand 7 in view of the camera module 16. While the hand is illuminated, the camera module 16 is controlled by the processor 24 to produce image data associated with a target region of tissue of the hand 7 which is within view of the camera module 16 and illuminated by the light source 14. In particular, the digital imaging sensor 17 of the camera module 16 is controlled to produce image data for each of the sensing elements forming the array of sensing elements. The image data for each sensing element has blue, green and red components, as described above.
  • At step S1030, the processor 24 determines a value for each of the blue, green and red components based on the received image data. In particular, the processor 24 generates a red value IR and a green value IG and a blue value IB for each sensing element. The red value IR is associated with the amount of red light received by the sensing element. The green value IG is associated with the amount of green light received by the same sensing element. The blue value IB is associated with the amount of blue light received by the same sensing element. The values are then used to generate a visual digital image and a compound digital image of the target region of tissue. The step of generating a visual digital image is optional. Each image comprises an array of pixels in which the location of each pixel corresponds to the location of a corresponding sensing element of the imaging sensor 17.
  • The processor 24 generates the visual digital image, as shown in FIG. 6A, using all three components to produce an image corresponding to that which is seen by the naked eye. The image is displayed on the screen 20 of the display unit 18 by the output device 26. The first image allows the target region of tissue to be inspected by a clinician to determine that the hand 7 is positioned correctly and that there are no anomalies that may affect analysis.
  • In order to generate the compound digital image, the processor 24 generates a compound value IC for each sensing element which corresponds to a respective pixel of the compound digital image.
  • A compound value IC for each pixel is generated by subtracting the green value IG from the red value IR. In order to compensate for differences in the amount of red and green light that is emitted by the light source 14, or to compensate for differences in the sensitivity of the imaging sensor 17 to red and green light, a scaling factor ‘a’ is applied to the green value IG. The value of ‘a’ may also set in accordance with other subjective factors related to representation and interpretation of the second image. The value of ‘a’ may be in the range 0.01 to 100, such as in the range 0.1 to 10 and may be in the range 1 to 5, such as 1. The compound value IC is therefore calculated as follows:

  • I C =I R −a.I G
  • The magnitude of the compound value IC provides an indication of the local distribution of blood within the target region of tissue associated with the pixel. This is because haemoglobin within blood absorbs green light much better than red light and so the amount of green light received at a sensing element is heavily dependent on the amount of blood within skin tissue whereas the amount of red light received at a sensing element is not.
  • To aid further explanation, FIG. 5 shows the spectral absorption by haemoglobin and haemoglobin species of light having wavelengths between 450 nm and 750 nm (as described at http://www.derangedphysiology.com/main/core-topics-intensive-care/arterial-blood-gas-interpretation/Chapter %203.0.1/absorption-spectroscopy-haemoglobin-species, which is incorporated herein by reference in its entirety).
  • Compared against the spectral response curves shown in FIG. 3, it can be seen that haemoglobin and the species oxygenated haemoglobin absorb more green light corresponding to the spectral range of the response curve G than they absorb red light corresponding to the spectral range of the response curve R. Consequently, the amount of green light absorbed at the target region of tissue is highly dependent on the amount of blood within the tissue. Conversely, the amount of red light absorbed at the target region of tissue has a much lower dependency on the amount of blood within the tissue.
  • The approximate ranges of the response curves G and R are superimposed on FIG. 5 as GR and RR, respectively. Although there is some overlap of the ranges GR and RR, it will be appreciated that overall proportion of green light absorbed by the haemoglobin within the tissue will be greater than the proportion of red light absorbed.
  • The green value IG for each pixel is proportional to the amount of green light detected by the imaging sensor 17 and so is inversely proportional to the amount of light absorbed. Therefore, a low green value IG, and by implication a high compound value IC, is associated with a large amount of blood within the region of tissue. The compound value IC therefore provides a reliable indicator of the amount of blood within tissue depicted by an associated pixel in the compound image.
  • In contrast, the skin tissue itself absorbs green and red light having spectral ranges corresponding to those shown in FIG. 3 substantially equally and so the value of IC is relatively unaffected by the nature of the skin tissue surrounding blood vessels.
  • In the embodiment shown, the compound value IC is converted for each pixel using a suitable scale, for example, based on brightness and/or a colour range to produce the second image, as shown in FIG. 6B. Areas having a greater amount (higher concentration) of blood within the tissue (i.e. comprising pixels having a relatively high IC-HIGH value) and areas having a lesser amount (lower concentration) of blood within the tissue (i.e. comprising pixels having a relatively low IC-LOW value) are delineated by contour lines within the image.
  • Although spectral ranges associated with high and low amounts of absorptivity by haemoglobin and oxygenated haemoglobin are utilised in the present embodiment to evaluate the concentration of blood within tissue, other spectral ranges could be selected in addition to, or as an alternative, that correspond to high and low amounts of absorptivity for other compounds that may be found within tissue and other compounds that may be found within blood.
  • It will be appreciated that, in the present embodiment, the light source 14 is configured to emit light having at least one wavelength, or range of wavelengths, which is both well absorbed by blood and which falls within the range of the response curve of the imaging sensor 17 associated with green light and at least one wavelength, or range of wavelengths, which is less well absorbed by blood and which falls within the range of the response curve of the imaging sensor 17 associated with red light.
  • FIG. 7 shows a flow chart illustrating a further method of using the apparatus 2 shown in FIG. 1 to monitor changes in blood perfusion within skin tissue. The apparatus 2 is used in conjunction with a restriction device in the form of an inflatable cuff (not shown) such as an Omron M3 Comfort Automatic Upper Arm Blood Pressure Monitor. In this example, the inflatable cuff is wrapped around a person's upper arm of the hand that is to be inspected.
  • At step S2010, a hand is placed on the base 6 of the apparatus 2. At step S2020, the light source 14 is activated to illuminate a target region of tissue of the hand. At step 2030, a first compound image is generated using components of the output of the camera module 16 as described above in connection with the process step S1030. A visual image may also be generated, as described in step S1030. However, such a step is optional and omitted in this instance. At step S2040, a first compound image is stored, transmitted or displayed on the integrated display unit 18. FIG. 8A shows a first compound image in which the hand is relatively well perfused. In this image, a scale having bands IC0, IC1, IC2, IC3, IC4 for different IC values is used to distinguish between areas having lowest IC values IC0 (i.e. low blood concentration) and areas having highest IC values IC4 (i.e. high blood concentration). Areas in which high and low concentrations of blood are present are therefore easy to identify within the image.
  • At step 2050, the inflatable cuff is inflated in order to restrict blood flow to the target region of tissue. After a suitable period of time has elapsed in which it can be expected that the restriction has reduced blood flow within the target region of tissue, the target region is illuminated again at step S2060, image data is captured by the camera module 16 and a second compound image is generated at step S2070. The suitable period of time may be at least 1 second or at least 2 seconds or at least 5 seconds. The light source 14 may be deactivated between capture of the first and second compound images or else remain activated throughout steps S2020 to S2060.
  • FIG. 8B shows a second compound image in which the hand 7 is poorly perfused following restriction by the inflatable cuff. There are, therefore, relatively few areas of the image in which indicate that high concentrations of blood are present in the target region of tissue. The highest compound value IC in this image is IC4 compared with IC4 in the first image which indicates that much lower concentrations of blood are present.
  • Comparison of first and second compound images, for example by a clinician, enables a qualitative assessment of blood perfusion to the target region of tissue. For example, if the inflation pressure of the cuff is known, the amount of blood perfusion in the second compound image in comparison the first compound image may be used to determine whether blood flow to the tissue is within normal bounds.
  • In further embodiments, restriction of blood flow to the target region of tissue may be done by a tourniquet or pressing against a vessel supplying blood to the tissue or by pressing against the target region of tissue itself.
  • FIG. 9 shows a variation of the method shown in FIG. 7.
  • At steps S3010 to S3050, which are the same as steps S2010 to S2050, a first compound image of a target region of tissue is obtained. An example of a first compound image is shown in FIG. 10A.
  • At step S3060, the target region of tissue is illuminated and image data is captured such that at step S3070, at least two consecutive compound images of the target region of tissue are captured after the cuff has been inflated. The consecutive images are stored, displayed or transmitted at step S3080 for analysis. At step S3090, the consecutive images are compared to determine whether the flow of blood within the target region has stabilised. The consecutive images may be compared visually by a clinician or automatically using image analysis software. If blood flow has not stabilised, steps S3060 to S3090 are repeated until it is determined that flow of blood within the target region of tissue is stable. An example of a compound image of the target region of tissue after it has been determined that the flow of blood within the tissue has stabilise is shown in FIG. 10B.
  • At step S3100, the time t1 at which blood flow has stabilised is recorded and the restriction removed immediately at step S3110 by deflation of the cuff. Steps S3120 to S3140 (which correspond to steps S3020 to S3040) are then followed to obtain a further compound image of the target region of tissue. At step S3150, the further compound image is compared against the first compound image to determine whether the distribution of blood within the tissue at the target region, and hence the flow of blood within the tissue, has returned/recovered to the original state prior to restriction of the blood flow. The comparison may once again be made visually by a clinician or automatically using suitable image analysis software. If distribution of blood has not returned to the original state, steps S3120 to S3150 are repeated. Once it is determined that the distribution of blood has returned, or has substantially returned, to its original state, the time t2 at which it does so is recorded. An example of a compound image obtained showing the distribution of blood within the target region of tissue once it has returned to its original state is shown in FIG. 100.
  • It will be appreciated that small movements of the tissue, hysteresis within the tissue and other variations will make it unlikely that blood flow within the tissue will return to the original state exactly. Therefore, suitable parameters may be used such as a proportion of the pixels of the compound image having a compound value IC which is within a predetermined percentage of the first compound image or a return to an average IC value for a selection of pixels of the image may be sufficient to determine that the distribution of blood has returned to the original state. The difference between time t2 and time t1 can then be calculated to determine a recovery time tR that provides an indication of the quality of blood perfusion at the target region.
  • A variant of the method shown in FIG. 9 has steps S3060 to S3100 omitted. Instead, a predetermined period of time is allowed to lapsed after inflation of the cuff which is sufficient to assume that blood flow has stabilised. The target region can then be imaged once the blood flow is known to have stabilised.
  • FIG. 11 shows a variation of the apparatus shown in FIG. 1 further comprising first and second linear polarising filters 28, 30. The first linear polarising filter 28 mounted in front of the camera module 16 and the second linear polarising filter 30 is mounted in front of the light source 14 so that light emitted by the light source 14 is polarised before reaching the target region of tissue of the hand 7 and light reflected by the tissue towards the camera module 16 is polarised before it reaches the camera module 16.
  • The first and second linear polarising filters are 28, 30 are arranged in a cross-polarised configuration so that light polarised by the second linear polarising filter 30 which has not been de-polarised before reaching the first linear polarising filter 28 will be blocked by the first linear polarising filter 28 and so prevented from reaching the imaging sensor 17 in the camera module 16. The polarising plane of the first linear polarising filter 28 is at 90 degrees to the polarising plane of the second linear polarising filter 30. The first and second linear polarising filters 28, 30 are set up in a cross-polarised configuration by placing a piece of flat aluminium foil (not shown) on the base 6 in the region at which the hand 7 is placed. The light source 14 is then used to illuminate the aluminium foil and images are captured of the illuminated portion of the aluminium foil. The first linear polarising filter 28 is then rotated with respect to the second linear polarising filter 30 until the light intensity of the captured images is at a minimum. At this orientation, the two polarising filters 28, 30 are considered to be in a cross-polarised configuration.
  • Only light T transmitted by the light source 14 and polarised by the second polarising filter 30 which is subsequently depolarised by the target region of tissue, for example on account of scattering events within the tissue, passes through the first linear polarising filter 28 to the camera module 16. Consequently, only light RS which has penetrated the epidermis 7 a of the skin tissue which undergoes multiple scattering events, and so has had an increased likelihood of being absorbed by blood vessels within the skin tissue, is used to generate an image of the target region. Light R which has been reflected without penetrating the skin tissue, and so which would provide an unreliable indication of the amount of blood within the skin tissue is prevented from reaching the camera module 16. The embodiment, when used to capture images using the methods outlined above, improves the quality and reliability of the images generated.
  • In some embodiments, a dedicated light source may be unnecessary since ambient light may be sufficient.
  • Camera modules comprising CCD or CMOS imaging sensors have been described with respect to the embodiments above. Other imaging sensors may be used that are suitable for detecting the spectral content of light and producing a digital image comprising a plurality of pixels in which each pixel can have a value that corresponds a spectral content of light received by the sensor at a corresponding portion of the sensor. Other imaging sensors having other suitable response curves may also be used.
  • Image data or images generated using image data can be processed or post-processed to enhance features of interest. For example, the brightness of images can be adjusted or contrast enhanced or colour adjusted or noise filter techniques or the like can be applied. Other imaging processing techniques may be used to highlight features of interest within the images.
  • Various light sources can be used for illumination. Light emitting diodes or a single diode may be used in accordance with the embodiments described above. Surface mounted diodes, which are compact, widely available, inexpensive, reliable, produce high-intensity light, have lower power consumption and are easy to integrate, may be used. Other light sources such as lasers, laser diodes, digital light projectors (DLPs), organic light emitting diodes (OLED) or incandescent light sources or the like may be used. The light source may be a broad-band or white light source such as the light source used in the embodiments described above, but may be a light source capable of illuminating the target region at two or more wavelengths, such as two monochromatic light sources, two laser diodes of different wavelengths, a multi-coloured LED or the like. Two light sources may be used, neither of which has an emission spectra extending over a region of overlap of response curves for the imaging sensor in which there is a significant response for each response curve. In an arrangement which comprises two light sources, the spectral range of one light source may be different from the spectral range of the other light source. For example, red and green LEDs could be used as respective light sources. An imaging sensor could be used which does not discriminate between the two spectral ranges and the light sources may be sequentially pulsed (i.e. activated and deactivated alternately) in order to obtain images at each of the respective spectral ranges. Diffuser of lens arrangements may be used to provide a reasonably uniform illumination across a region of interest or to focus light on particular areas of interest.
  • The light source, camera module and display unit may be incorporated into a portable hand-held device having a single housing in which the components are housed. For example, a hand-held digital camera unit having an integrated flash unit could be configured to generate images in accordance with the imaging methods described above.
  • In some embodiments, the portable hand-held device can be a smartphone, tablet, or the like with an integrated camera and a flash. For example, as illustrated in FIG. 12, the hand-held device can be a smartphone 1200. The camera can be utilised to capture one or more images or videos. For instance, one or more images can be captured using standard, burst capture, such as IPHONE™ live photo capture. Capturing one or more images or videos can permit processing of the differential in absorption substantially in real time or offline.
  • One or more polarising filters (as described herein) can be positioned over the flash. The flash can be turned on for the duration of the image or video capture. An orthogonal polarising filter (whose polarising plane can be at 90 degrees to polarising plane(s) of the one or more filters positioned over the flash as described herein) can be positioned over an image lens of the camera. In some cases, the one or more filters positioned over the flash and the orthogonal filter positioned over the image lens are connected to be in cross-polarised configuration as described herein. The one or more filters positioned over the flash can be tinted to prioritise only the frequencies of interest as described herein.
  • Alternatively or additionally, a lens, such as macro lens 1210, can be used over the image lens of the camera. Alternatively or additionally, a separate illumination source can be used. In any of the embodiments described herein, Eulerian amplification techniques can be used in the analysis, as described in U.S. Provisional Patent Application Nos. 62/506,524, filed May 15, 2017 and 62/506,551, filed May 15, 2017, each of which is incorporated herein by reference in its entirety. Eulerian magnification can, for example, amplify variations in absorption due to the pulse providing bursts of blood.
  • It will be appreciated that throughout this specification reference is made to a wound. It is to be understood that the term wound is to be broadly construed and encompasses open and closed wounds in which skin is torn, cut or punctured or where trauma causes a contusion, or any other superficial or other conditions or imperfections on the skin of a patient or otherwise that benefit from reduced pressure treatment. A wound is thus broadly defined as any damaged region of tissue where fluid may or may not be produced. Examples of such wounds include, but are not limited to, abdominal wounds or other large or incisional wounds, either as a result of surgery, trauma, sternotomies, fasciotomies, or other conditions, dehisced wounds, acute wounds, chronic wounds, subacute and dehisced wounds, traumatic wounds, flaps and skin grafts, lacerations, abrasions, contusions, burns, diabetic ulcers, pressure ulcers, stoma, surgical wounds, trauma and venous ulcers or the like.
  • In the drawings like reference numerals refer to like parts.
  • Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of them mean “including but not limited to” and they are not intended to (and do not) exclude other moieties, additives, components, integers or steps. Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
  • Features, integers, characteristics or groups described in conjunction with a particular aspect, embodiment or example of the disclosure are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of the features and/or steps are mutually exclusive. The disclosure is not restricted to any details of any foregoing embodiments. The disclosure extends to any novel one, or novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
  • The reader's attention is directed to all papers and documents which are filed concurrently with or previous to this specification in connection with this application and which are open to public inspection with this specification, and the contents of all such papers and documents are incorporated herein by reference in their entireties.

Claims (19)

1-55. (canceled)
56. An apparatus for imaging blood within a target region of tissue, comprising:
a visible light source configured to illuminate at least a portion of the target region of tissue with light where blood flow has been restricted, the light having at least a first spectral range and a second spectral range;
an imaging sensor configured to contemporaneously capture an image data of at least a portion of the target region of tissue illuminated by the light while blood flow is restored to the target region of tissue; and
a controller configured to receive the image data from the imaging sensor and process the image data to generate compound image data associated with an amount of blood within the target region of tissue.
57. The apparatus of claim 56, wherein the absorptivity by blood of light having the first spectral range is less than the absorptivity by blood of light having the second spectral range.
58. The apparatus of claim 56, wherein the controller is configured to contemporaneously capture the image data associated with light received by the imaging sensor having the first spectral range and image data associated with light received by the imaging sensor having the second spectral range.
59. The apparatus of claim 56, wherein the visible light source is configured to illuminate the portion of the target region of tissue with a linearly polarised light.
60. The apparatus of claim 59, further comprising a linearly polarising filter arranged in front of the imaging sensor such that, in use, the linearly polarising filter is disposed between the imaging sensor and the target region of tissue, wherein the linearly polarising filter is arranged to block the linearly polarised light reflected by the target region of tissue.
61. The apparatus of claim 56, wherein the first spectral range corresponds to a spectral range associated with red light and second spectral range corresponds to a spectral range associated with green light.
62. A method of imaging blood within a target region of tissue comprising:
restricting blood flow to the target region of tissue;
after removing the restriction, illuminating the target region of tissue using visible light having at least a first spectral range and a second spectral range, such that the light is at least one of scattered or reflected by the target region of tissue;
arranging an imaging sensor to receive light at least one of scattered or reflected by the target region of tissue; and
using the imaging sensor to contemporaneously capture at least one image of at least a portion of the target region of tissue.
63. The method of claim 62 wherein the visible light is linearly polarized.
64. The method of claim 63 further comprising disposing a linearly polarising filter positioned between the target region of tissue and the imaging sensor such that scattered light which has been depolarised by the target region of tissue is transmitted by the linearly polarising filter and reflected light which remains polarised is blocked by the linearly polarising filter.
65. The method of claim 62 wherein the absorptivity by blood of the light having the first spectral range is less than the absorptivity by blood of the light having the second spectral range.
66. The method of claim 62 wherein the first spectral range corresponds to a spectral range associated with red light and the second spectral range corresponds to a spectral range associated with green light.
67. A method of imaging blood within a target region of tissue comprising:
receiving an image data associated with linearly polarized light that has been at least one of reflected or scattered by the target region of tissue that was illuminated during re-perfusion by a visible light source having two spectral ranges; and
processing the image data to generate a compound image associated with an amount of blood in the target region of tissue.
68. The method of claim 67, wherein the two spectral ranges comprise a first spectral range and a second spectral range, and the absorptivity by blood of the light having the first spectral range is less than the absorptivity by blood of the light having the second spectral range.
69. The method of claim 68 wherein the first spectral range corresponds to a spectral range associated with red light and the second spectral range corresponds to a spectral range associated with green light.
70. The method of claim 68, wherein the image data comprises a first image data associated with the first spectral range and a second image data associated with the second spectral range, wherein the first image data and the second image data are captured contemporaneously.
71. The method of claim 67, further comprising receiving image data associated with light that has been reflected or scattered by the target region of tissue that was illuminated before re-perfusion.
72. The method of claim 71, further comprising receiving image data associated with light that has been reflected or scattered by the target region of tissue that was illuminated after re-perfusion.
73. The method of claim 67, further comprising receiving image data associated with light that has been reflected or scattered by the target region of tissue that was illuminated after re-perfusion.
US17/739,916 2017-03-09 2022-05-09 Apparatus and method for imaging blood in a target region of tissue Pending US20220330857A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/739,916 US20220330857A1 (en) 2017-03-09 2022-05-09 Apparatus and method for imaging blood in a target region of tissue

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB1703772.2 2017-03-09
GBGB1703771.4A GB201703771D0 (en) 2017-03-09 2017-03-09 Apparatus and method
GBGB1703772.2A GB201703772D0 (en) 2017-03-09 2017-03-09 Apparatus and method
GB1703771.4 2017-03-09
PCT/EP2018/055945 WO2018162732A1 (en) 2017-03-09 2018-03-09 Apparatus and method for imaging blood in a target region of tissue
US201916491959A 2019-09-06 2019-09-06
US17/739,916 US20220330857A1 (en) 2017-03-09 2022-05-09 Apparatus and method for imaging blood in a target region of tissue

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US16/491,959 Continuation US11324424B2 (en) 2017-03-09 2018-03-09 Apparatus and method for imaging blood in a target region of tissue
PCT/EP2018/055945 Continuation WO2018162732A1 (en) 2017-03-09 2018-03-09 Apparatus and method for imaging blood in a target region of tissue

Publications (1)

Publication Number Publication Date
US20220330857A1 true US20220330857A1 (en) 2022-10-20

Family

ID=61768251

Family Applications (2)

Application Number Title Priority Date Filing Date
US16/491,959 Active 2038-10-09 US11324424B2 (en) 2017-03-09 2018-03-09 Apparatus and method for imaging blood in a target region of tissue
US17/739,916 Pending US20220330857A1 (en) 2017-03-09 2022-05-09 Apparatus and method for imaging blood in a target region of tissue

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US16/491,959 Active 2038-10-09 US11324424B2 (en) 2017-03-09 2018-03-09 Apparatus and method for imaging blood in a target region of tissue

Country Status (3)

Country Link
US (2) US11324424B2 (en)
EP (1) EP3592230A1 (en)
WO (1) WO2018162732A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220143524A1 (en) * 2019-03-22 2022-05-12 Lego A/S Rechargeable Interactive Toy

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3023772A1 (en) 2016-05-13 2017-11-16 Smith & Nephew Plc Sensor enabled wound monitoring and therapy apparatus
US11324424B2 (en) 2017-03-09 2022-05-10 Smith & Nephew Plc Apparatus and method for imaging blood in a target region of tissue
EP3592212B1 (en) 2017-03-09 2024-08-07 Smith & Nephew plc Wound dressing
SG11201909449TA (en) 2017-04-11 2019-11-28 Smith & Nephew Component positioning and stress relief for sensor enabled wound dressings
US12033738B2 (en) 2017-05-15 2024-07-09 Smith & Nephew Plc Negative pressure wound therapy system using eulerian video magnification
WO2018210692A1 (en) 2017-05-15 2018-11-22 Smith & Nephew Plc Wound analysis device and method
EP3641627B1 (en) 2017-06-23 2023-05-31 Smith & Nephew PLC Positioning of sensors for sensor enabled wound monitoring or therapy
GB201804502D0 (en) 2018-03-21 2018-05-02 Smith & Nephew Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
GB201809007D0 (en) 2018-06-01 2018-07-18 Smith & Nephew Restriction of sensor-monitored region for sensor-enabled wound dressings
CN111093726B (en) 2017-08-10 2023-11-17 史密夫及内修公开有限公司 Sensor positioning for performing wound monitoring or treatment of sensors
GB201718870D0 (en) 2017-11-15 2017-12-27 Smith & Nephew Inc Sensor enabled wound therapy dressings and systems
US11759144B2 (en) 2017-09-10 2023-09-19 Smith & Nephew Plc Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings
GB201804971D0 (en) 2018-03-28 2018-05-09 Smith & Nephew Electrostatic discharge protection for sensors in wound therapy
GB201718859D0 (en) 2017-11-15 2017-12-27 Smith & Nephew Sensor positioning for sensor enabled wound therapy dressings and systems
JP7282079B2 (en) 2017-09-27 2023-05-26 スミス アンド ネフュー ピーエルシー PH Sensing for Sensor-Enabled Negative Pressure Wound Monitoring and Therapy Devices
US11839464B2 (en) 2017-09-28 2023-12-12 Smith & Nephew, Plc Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus
EP3709943B1 (en) 2017-11-15 2024-07-24 Smith & Nephew PLC Integrated sensor enabled wound monitoring and/or therapy dressings and systems
US11266345B2 (en) * 2018-07-16 2022-03-08 Swift Medical Inc. Apparatus for visualization of tissue
EP3849401A1 (en) 2018-09-12 2021-07-21 Smith & Nephew plc Device, apparatus and method of determining skin perfusion pressure
DE102018125050A1 (en) 2018-10-10 2020-04-16 Osram Opto Semiconductors Gmbh Optoelectronic sensor
GB201820927D0 (en) 2018-12-21 2019-02-06 Smith & Nephew Wound therapy systems and methods with supercapacitors
GB2616370B (en) 2019-03-18 2023-12-06 Smith & Nephew Design rules for sensor integrated substrates
GB201914443D0 (en) 2019-10-07 2019-11-20 Smith & Nephew Sensor enabled negative pressure wound monitoring apparatus with different impedances inks
EP4199810A4 (en) * 2020-08-23 2024-03-13 My-Or Diagnostics Ltd. Apparatus and method for determining hemoglobin levels

Family Cites Families (413)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL46795A0 (en) 1974-04-19 1975-05-22 Moreno J Synthetic surgical dressing auxiliary tool for work on pipes
US3896802A (en) 1974-04-19 1975-07-29 American Cyanamid Co Flexible flocked dressing
US4334530A (en) 1980-09-12 1982-06-15 Hassell Donald S Indicia-bearing adhesive bandages
US5090410A (en) 1989-06-28 1992-02-25 Datascope Investment Corp. Fastener for attaching sensor to the body
US5690610A (en) 1991-03-04 1997-11-25 Nichiban Co., Ltd. Adhesive material for hemostasis and a method for hemostasis
US5642096A (en) 1992-03-20 1997-06-24 Paromed Medizintechnik Gmbh Device for prevention of ulcers in the feet of diabetes patients
SE500972C2 (en) 1992-03-30 1994-10-10 Moelnlycke Ab Method and apparatus for manufacturing wound dressings and a wound dressing made by the method
US5253654A (en) 1992-04-30 1993-10-19 Thomas Berten R Orthopedic weight monitor
US6178342B1 (en) 1993-09-09 2001-01-23 Vasamedics Surface perfusion pressure monitoring system
US5678448A (en) 1994-01-14 1997-10-21 Fullen Systems, Inc. System for continuously measuring forces applied by the foot
GB9615895D0 (en) 1996-07-29 1996-09-11 Thames Medical Ltd Pulse oximeter
DE19722075C1 (en) 1997-05-27 1998-10-01 Wilhelm Dr Med Fleischmann Medication supply to open wounds
US7206623B2 (en) 2000-05-02 2007-04-17 Sensys Medical, Inc. Optical sampling interface system for in vivo measurement of tissue
US5836990A (en) 1997-09-19 1998-11-17 Medtronic, Inc. Method and apparatus for determining electrode/tissue contact
US6381482B1 (en) 1998-05-13 2002-04-30 Georgia Tech Research Corp. Fabric or garment with integrated flexible information infrastructure
US6095992A (en) 1998-04-06 2000-08-01 Augustine Medical, Inc. Wound treatment apparatus for normothermic treatment of wounds
US6343224B1 (en) 1998-10-15 2002-01-29 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage apparatus
FR2785544B1 (en) 1998-11-09 2001-01-05 Lhd Lab Hygiene Dietetique TRANSFER ELECTRODE OF AN ELECTRIC CURRENT CROSSING THE SKIN OF A PATIENT
AU3207300A (en) 1999-01-21 2000-08-07 Rhoda Zione Wound management system and wound dressing
US7047054B2 (en) 1999-03-12 2006-05-16 Cas Medical Systems, Inc. Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring
US6856821B2 (en) 2000-05-26 2005-02-15 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US20030208148A1 (en) 1999-11-01 2003-11-06 Sullivan John Patrick Adhesive bandage with soft, three-dimensional toy figure
US6517484B1 (en) 2000-02-28 2003-02-11 Wilk Patent Development Corporation Ultrasonic imaging system and associated method
US6639674B2 (en) 2000-03-28 2003-10-28 Board Of Regents, The University Of Texas System Methods and apparatus for polarized reflectance spectroscopy
KR100810989B1 (en) 2000-04-17 2008-03-11 바이보메트릭스, 인크. Systems and methods for ambulatory monitoring of physiological signs
US7520875B2 (en) 2001-04-06 2009-04-21 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US7217266B2 (en) * 2001-05-30 2007-05-15 Anderson R Rox Apparatus and method for laser treatment with spectroscopic feedback
EP1405044A1 (en) 2001-07-02 2004-04-07 Battelle Memorial Institute Intelligent microsensor module
DE60315805D1 (en) 2002-01-23 2007-10-04 Bang & Olufsen Medicom As BLOOD PRESSURE MEASURING DEVICE WITH CUFF OF TWO OPENING CONCAVES SHELL PARTS
US6980852B2 (en) 2002-01-25 2005-12-27 Subqiview Inc. Film barrier dressing for intravascular tissue monitoring system
GB0202654D0 (en) 2002-02-06 2002-03-20 Univ Nottingham Examination of superficial regions of a body
US7158660B2 (en) 2002-05-08 2007-01-02 Gee Jr James W Method and apparatus for detecting structures of interest
US6879850B2 (en) 2002-08-16 2005-04-12 Optical Sensors Incorporated Pulse oximeter with motion detection
US20070100666A1 (en) 2002-08-22 2007-05-03 Stivoric John M Devices and systems for contextual and physiological-based detection, monitoring, reporting, entertainment, and control of other devices
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
US8111165B2 (en) 2002-10-02 2012-02-07 Orthocare Innovations Llc Active on-patient sensor, method and system
JP2004158605A (en) 2002-11-06 2004-06-03 Konica Minolta Holdings Inc Printed wiring board and method of mounting the same to conductive housing
GB0228375D0 (en) 2002-12-05 2003-01-08 Innovation And Entpr Off Of Wound mapping
WO2004071279A2 (en) 2003-02-07 2004-08-26 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Surgical drain with sensors for tissue monitoring
GB0303797D0 (en) 2003-02-19 2003-03-26 Huntleigh Technology Plc Blood assessment
US7706862B2 (en) 2003-04-17 2010-04-27 Research Foundation Of The City University Of New York Detecting human cancer through spectral optical imaging using key water absorption wavelengths
WO2005009236A1 (en) 2003-07-31 2005-02-03 Koninklijke Philips Electronics N.V. Method and apparatus for determining a property of a fluid which flows through a biological tubular structure with variable numerical aperture
WO2005023361A2 (en) 2003-09-10 2005-03-17 Power Paper Ltd. Disposable electric bandage
EP1670347A4 (en) 2003-09-19 2011-05-18 Gen Hospital Corp Fluorescence polarization imaging devices and methods
TWI220787B (en) 2003-10-24 2004-09-01 Asustek Comp Inc Electric device with electrostatic discharge protection structure thereof
US20070293781A1 (en) 2003-11-04 2007-12-20 Nathaniel Sims Respiration Motion Detection and Health State Assesment System
CN1894796B (en) 2003-12-15 2010-09-01 株式会社半导体能源研究所 Process for fabricating thin film integrated circuit device, noncontact thin film integrated circuit device and its fabrication process
US7532746B2 (en) * 2004-01-16 2009-05-12 Vue Tek Scientific, Llc System and method for locating and accessing a blood vessel
DE602005022282D1 (en) 2004-02-27 2010-08-26 Koninkl Philips Electronics Nv PORTABLE WIRELESS DEVICE FOR MONITORING, ANALYSIS AND COMMUNICATION OF THE PHYSIOLOGICAL STATUS
WO2005084537A1 (en) 2004-03-08 2005-09-15 Medicus Engineering Aps A method and an instrument for measuring of physiological parameters
DK1734858T3 (en) 2004-03-22 2014-10-20 Bodymedia Inc NON-INVASIVE TEMPERATURE MONITORING DEVICE
US7884258B2 (en) 2004-04-13 2011-02-08 Boehringer Technologies, L.P. Wound contact device
GB0408492D0 (en) 2004-04-16 2004-05-19 Univ Strathclyde Performance measurement of wound dressings
US7201063B2 (en) 2004-04-30 2007-04-10 Taylor Geoffrey L Normal force gradient/shear force sensors and method of measuring internal biological tissue stress
US7521292B2 (en) 2004-06-04 2009-04-21 The Board Of Trustees Of The University Of Illinois Stretchable form of single crystal silicon for high performance electronics on rubber substrates
US20070270678A1 (en) 2004-06-18 2007-11-22 Fadem Kalford C Wireless Electrode for Biopotential Measurement
SE0401632D0 (en) 2004-06-24 2004-06-24 Innovation Team Ab Means and ways to detect blood leakage from wounds
US20060052678A1 (en) 2004-09-02 2006-03-09 Drinan Darrel D Monitoring platform for wound and ulcer monitoring and detection
US20060058690A1 (en) 2004-09-10 2006-03-16 Optical Sensors, Inc. Method and instrument for automated measurement of skin perfusion pressure
US8498681B2 (en) 2004-10-05 2013-07-30 Tomophase Corporation Cross-sectional mapping of spectral absorbance features
DE602005011984D1 (en) 2004-10-05 2009-02-05 Koninkl Philips Electronics Nv SKIN TREATMENT DEVICE WITH RADIATION EMISSION PROTECTION
NL1027236C2 (en) 2004-10-13 2006-04-18 Innova Medical V O F Dressing for a wounded part comprises an orientation-indicating device for helping to orient the body part with respect to the horizontal
US9597024B2 (en) 2005-02-09 2017-03-21 Medici Instruments Llc Methods and apparatuses for noninvasive determinations of analytes
DK1854342T3 (en) 2005-02-28 2014-09-22 Commw Scient Ind Res Org FLEXIBLE ELECTRONIC DEVICE
US20060241495A1 (en) 2005-03-23 2006-10-26 Eastman Kodak Company Wound healing monitoring and treatment
JP2009500047A (en) 2005-04-14 2009-01-08 イダルゴ リミテッド Apparatus and method for monitoring
US8060174B2 (en) 2005-04-15 2011-11-15 Dexcom, Inc. Analyte sensing biointerface
EP1933697A4 (en) 2005-09-06 2011-05-25 Vaesamed Inc System for automated measurement of skin perfusion pressure
AU2006287463A1 (en) 2005-09-06 2007-03-15 Tyco Healthcare Group Lp Self contained wound dressing with micropump
CA2620401C (en) 2005-09-07 2016-05-24 Tyco Healthcare Group Lp Self contained wound dressing apparatus
EP1922095A2 (en) 2005-09-07 2008-05-21 Tyco Healthcare Group LP Wound dressing with vacuum reservoir
GB0519836D0 (en) 2005-09-29 2005-11-09 Smartlife Technology Ltd Contact sensors
US8032210B2 (en) 2005-10-06 2011-10-04 Spinematrix, Inc. EMG diagnostic system and method
US7420472B2 (en) 2005-10-16 2008-09-02 Bao Tran Patient monitoring apparatus
US7877866B1 (en) 2005-10-26 2011-02-01 Second Sight Medical Products, Inc. Flexible circuit electrode array and method of manufacturing the same
US8333874B2 (en) 2005-12-09 2012-12-18 Flexible Medical Systems, Llc Flexible apparatus and method for monitoring and delivery
JP5478071B2 (en) 2005-12-22 2014-04-23 コーニンクレッカ フィリップス エヌ ヴェ System and method for magnetic induction tomography
US7816577B2 (en) 2006-02-13 2010-10-19 Aalnex, Inc. Wound shield
CA2538940A1 (en) 2006-03-03 2006-06-22 James W. Haslett Bandage with sensors
DE102006045138A1 (en) 2006-03-27 2007-11-15 Siemens Ag Device, sensor, sensor element and method for measuring the spinal column course and changes in the course of the spine
US7607243B2 (en) 2006-05-03 2009-10-27 Nike, Inc. Athletic or other performance sensing systems
US8644911B1 (en) 2006-06-30 2014-02-04 Hypermed Imaging, Inc. OxyVu-1 hyperspectral tissue oxygenation (HTO) measurement system
GB2439750A (en) 2006-07-06 2008-01-09 Wound Solutions Ltd Monitoring a limb wound
WO2008006150A1 (en) 2006-07-11 2008-01-17 Citech Research Ip Pty Ltd Bio-activity data capture and transmission
WO2008010604A1 (en) 2006-07-19 2008-01-24 School Juridical Person Kitasato Gakuen Blood vessel imaging device and system for analyzing blood vessel distribution
US9254220B1 (en) 2006-08-29 2016-02-09 Vasamed, Inc. Method and system for assessing severity and stage of peripheral arterial disease and lower extremity wounds using angiosome mapping
US7890153B2 (en) 2006-09-28 2011-02-15 Nellcor Puritan Bennett Llc System and method for mitigating interference in pulse oximetry
GB0620061D0 (en) 2006-10-10 2006-11-22 Medical Device Innovations Ltd Oesophageal treatment apparatus and method
US7785301B2 (en) 2006-11-28 2010-08-31 Vadim V Yuzhakov Tissue conforming microneedle array and patch for transdermal drug delivery or biological fluid collection
US8019401B1 (en) 2006-12-04 2011-09-13 Smithmarks, Inc. Stretchable electrode and method of making physiologic measurements
NZ551819A (en) 2006-12-04 2009-03-31 Zephyr Technology Ltd Impact detection system
US8238996B2 (en) 2006-12-05 2012-08-07 Tyco Healthcare Group Lp Electrode array
US8100834B2 (en) 2007-02-27 2012-01-24 J&M Shuler, Inc. Method and system for monitoring oxygenation levels of a compartment for detecting conditions of a compartment syndrome
US7687678B2 (en) 2007-05-10 2010-03-30 Cisco Technology, Inc. Electronic bandage with flexible electronic controller
ATE524108T1 (en) 2007-06-19 2011-09-15 Biocompatibles Uk Ltd METHOD AND DEVICE FOR MEASURING SKIN TEXTURE
CA2696932A1 (en) 2007-08-22 2009-02-26 Commonwealth Scientific And Industrial Research Organisation A system, garment and method
WO2009036313A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Adherent device with multiple physiological sensors
WO2009052607A1 (en) 2007-10-24 2009-04-30 Perceptronix Medical Inc. Method and apparatus for microvascular oxygenation imaging
US8116838B2 (en) 2007-11-27 2012-02-14 Carnegie Mellon University Medical device for diagnosing pressure ulcers
GB0723898D0 (en) 2007-12-06 2008-01-16 Wound Solutions Ltd Wound treatment device and method
EP2242537A1 (en) 2007-12-10 2010-10-27 Isis Biopolymer LLC Iontophoretic drug delivery device and software application
US8366692B2 (en) 2008-01-08 2013-02-05 Richard Scott Weston Sustained variable negative pressure wound treatment and method of controlling same
JP2011509150A (en) 2008-01-08 2011-03-24 カーディアック ペースメイカーズ, インコーポレイテッド Impedance measuring apparatus and impedance measuring method using embedded device
US20090177051A1 (en) 2008-01-09 2009-07-09 Heal-Ex, Llc Systems and methods for providing sub-dressing wound analysis and therapy
GB0801264D0 (en) 2008-01-24 2008-02-27 Univ Ulster Electrically enhances wound healing system and method
WO2009103034A2 (en) 2008-02-13 2009-08-20 Board Of Regents, The University Of Texas System System, method and apparatus for an amorphous iridium oxide film ph sensor
WO2009114624A2 (en) 2008-03-12 2009-09-17 Bluesky Medical Group Inc. Negative pressure dressing and method of using same
US8161826B1 (en) 2009-03-05 2012-04-24 Stryker Corporation Elastically stretchable fabric force sensor arrays and methods of making
JP2009225863A (en) 2008-03-19 2009-10-08 Nemoto Kyorindo:Kk Double-sided adhesive sheet with peeling sheet
WO2009120951A2 (en) 2008-03-28 2009-10-01 Nordson Corporation Automated conformal coating inspection system and methods of use
US7792334B2 (en) 2008-03-31 2010-09-07 Immersion Corporation Locating blood vessels
CN102036600B (en) 2008-05-23 2014-08-06 皇家飞利浦电子股份有限公司 A substrate layer adapted to carry sensors, actuators or electrical components
WO2009141777A1 (en) 2008-05-23 2009-11-26 Koninklijke Philips Electronics N.V. A substrate layer adapted to carry sensors, actuators or electrical components
US8480641B2 (en) 2008-06-13 2013-07-09 Premco Medical Systems, Inc. Negative pressure wound treatment apparatus and method
WO2010009385A1 (en) 2008-07-18 2010-01-21 Flexcon Company, Inc. High impedance signal detection systems and methods for use in electrocardiogram detection systems
US20100022990A1 (en) 2008-07-25 2010-01-28 Boehringer Technologies, L.P. Pump system for negative pressure wound therapy and improvements thereon
WO2010020919A1 (en) 2008-08-22 2010-02-25 Koninklijke Philips Electronics N.V. Monitoring of a fluid accumulation in a body of a person
US8389862B2 (en) 2008-10-07 2013-03-05 Mc10, Inc. Extremely stretchable electronics
US8503712B2 (en) * 2008-12-31 2013-08-06 Motorola Mobility Llc Method and apparatus for determining blood oxygenation using a mobile communication device
FR2940904B1 (en) 2009-01-13 2012-08-31 Urgo Laboratoires INTERFACE PRESSURE MEASURING SYSTEM
DE102009008885A1 (en) 2009-02-14 2010-08-26 Fresenius Medical Care Deutschland Gmbh Device for detecting moisture for a device for monitoring access to a patient, in particular for monitoring the vascular access in the case of extracorporeal blood treatment
WO2010105053A2 (en) 2009-03-13 2010-09-16 Corventis, Inc. Acute patient management for military and emergency applications
US11278237B2 (en) 2010-04-22 2022-03-22 Leaf Healthcare, Inc. Devices, systems, and methods for preventing, detecting, and treating pressure-induced ischemia, pressure ulcers, and other conditions
US8823934B2 (en) 2009-03-27 2014-09-02 Brightex Bio-Photonics Llc Methods and systems for imaging and modeling skin using polarized lighting
US8332053B1 (en) 2009-04-28 2012-12-11 Hrl Laboratories, Llc Method for fabrication of a stretchable electronic skin
US20110004088A1 (en) 2009-05-13 2011-01-06 Kurt Paul Grossman The ecg shirt
GB0912009D0 (en) 2009-07-10 2009-08-19 Univ Strathclyde Sensor
US8535282B2 (en) 2009-07-14 2013-09-17 Southwest Research Institute Wound healing sensor techniques
EP2464412A4 (en) 2009-08-13 2014-08-20 Michael Simms Shuler Methods and dressing systems for promoting healing of injured tissue
EP2467058A4 (en) 2009-08-17 2014-08-06 Univ California Distributed external and internal wireless sensor systems for characterization of surface and subsurface biomedical structure and condition
US20110218756A1 (en) 2009-10-01 2011-09-08 Mc10, Inc. Methods and apparatus for conformal sensing of force and/or acceleration at a person's head
GB0921477D0 (en) 2009-12-08 2010-01-20 Moor Instr Ltd Apparatus for measuring blood parameters
US10441185B2 (en) 2009-12-16 2019-10-15 The Board Of Trustees Of The University Of Illinois Flexible and stretchable electronic systems for epidermal electronics
CA2784997C (en) 2009-12-30 2018-06-19 Jacques Beauvais Carbon nanotubes based sensing elements and system for monitoring and mapping force, strain and stress
WO2011082420A1 (en) 2010-01-04 2011-07-07 John Stephan Illuminatable apparatus and method of manufacturing same
FR2955763B1 (en) 2010-02-02 2012-03-09 Commissariat Energie Atomique BI-SPECTRAL PEROPERATIVE OPTIC PROBE
EP2538841A2 (en) * 2010-02-26 2013-01-02 Myskin, Inc. Analytic methods of tissue evaluation
JP5663900B2 (en) 2010-03-05 2015-02-04 セイコーエプソン株式会社 Spectroscopic sensor device and electronic device
WO2011113070A1 (en) 2010-03-07 2011-09-15 Centauri Medical, INC. Systems, devices and methods for preventing, detecting, and treating pressure-induced ischemia, pressure ulcers, and other conditions
US8553223B2 (en) 2010-03-31 2013-10-08 Covidien Lp Biodegradable fibers for sensing
US9427506B2 (en) 2010-03-31 2016-08-30 Kci Licensing, Inc. System and method for locating fluid leaks at a drape using sensing techniques
US20130317367A1 (en) 2010-05-04 2013-11-28 Michael Simms Shuler Method and system for providing versatile nirs sensors
SG185131A1 (en) 2010-05-08 2012-12-28 Univ California Sem scanner sensing apparatus, system and methodology for early detection of ulcers
EP2568874A4 (en) 2010-05-08 2014-10-29 Univ California Method, system, and apparatus for pressure image registration
US8182425B2 (en) 2010-05-18 2012-05-22 Johnson & Johnson Consumer Companies, Inc. Method for measuring skin hydration
US8525340B2 (en) 2010-06-11 2013-09-03 Premitec, Inc. Flexible electronic devices and related methods
WO2012001465A1 (en) 2010-06-29 2012-01-05 Indian Institute Of Technology Kanpur Flexible temperature sensor and sensor array
US9314175B2 (en) 2010-07-08 2016-04-19 TCI3—Pressure Applications, LLC Compartment syndrome monitoring systems and methods
US9585620B2 (en) 2010-07-27 2017-03-07 Carefusion 303, Inc. Vital-signs patch having a flexible attachment to electrodes
US20120029306A1 (en) 2010-07-27 2012-02-02 Carefusion 303, Inc. Vital-signs monitor with encapsulation arrangement
US20120029307A1 (en) 2010-07-27 2012-02-02 Carefusion 303, Inc. Vital-signs monitor with spaced electrodes
US20120316486A1 (en) 2010-08-20 2012-12-13 Andrew Cheung Surgical Component Navigation Systems And Methods
US9000251B2 (en) 2010-08-26 2015-04-07 Combat Medical Systems, Llc Draining wound dressing
US8579872B2 (en) 2010-10-27 2013-11-12 Kci Licensing, Inc. Reduced-pressure systems, dressings, and methods employing a wireless pump
DE102010051459A1 (en) 2010-11-17 2012-05-24 Harald Pötzschke Wound monitoring with textile transducer systems
SI2640262T1 (en) 2010-11-17 2015-10-30 Smart Solutions Technologies, S.L. Sensor for acquiring physiological signals
WO2012074509A1 (en) 2010-11-30 2012-06-07 Avery Dennison Corporation Sensing patch applications
JP5965409B2 (en) 2010-12-08 2016-08-03 コンバテック・テクノロジーズ・インコーポレイテッドConvatec Technologies Inc Integrated system for assessing wound exudate
US20120165717A1 (en) 2010-12-22 2012-06-28 Convatec Technologies Inc. Medical compression product, system utilizing such product, and program for use therewith
US8868794B2 (en) * 2010-12-27 2014-10-21 Medtronic, Inc. Application limitations for a medical communication module and host device
SG191880A1 (en) 2011-01-19 2013-08-30 Univ California Apparatus, systems, and methods for tissue oximetry and perfusion imaging
GB2487758A (en) 2011-02-03 2012-08-08 Isansys Lifecare Ltd Health monitoring electrode assembly
EP2672893B1 (en) 2011-02-13 2021-03-31 Edwards Lifesciences Corporation Nirs sensor assembly including electrically conductive and optically transparent emi shielding
JP2014514032A (en) 2011-03-11 2014-06-19 プロテウス デジタル ヘルス, インコーポレイテッド Wearable personal body-related devices with various physical configurations
US8818478B2 (en) 2011-03-31 2014-08-26 Adidas Ag Sensor garment
US8838228B2 (en) 2011-04-15 2014-09-16 Arthur Beisang, III Systems and methods for reducing the proliferation of microorganisms
US20120271265A1 (en) 2011-04-20 2012-10-25 Frederick Michael Langdon Zero-Strain Stretch Laminate with Enhanced Strength, Appearance and Tactile Features, and Absorbent Articles Having Components Formed Therefrom
KR20120119523A (en) 2011-04-21 2012-10-31 방부복 Blood vessel indicating device
US10117705B2 (en) 2011-05-16 2018-11-06 Covidien Lp Optical recognition of tissue and vessels
US8934965B2 (en) 2011-06-03 2015-01-13 The Board Of Trustees Of The University Of Illinois Conformable actively multiplexed high-density surface electrode array for brain interfacing
WO2012178161A1 (en) 2011-06-24 2012-12-27 Kci Licensing, Inc. Medical drapes, devices, and systems employing a holographically-formed polymer dispersed liquid crystal (h-pdlc) device
JP5450527B2 (en) 2011-08-10 2014-03-26 富士フイルム株式会社 Endoscope device
WO2013023071A1 (en) 2011-08-11 2013-02-14 Reflectance Medical, Inc. Patient interface for reusable optical sensor
WO2013026999A1 (en) 2011-08-19 2013-02-28 Pulse Innovate Ltd A wound management system
WO2013027359A1 (en) 2011-08-19 2013-02-28 株式会社村田製作所 Living organism sensor
IN2014CN02072A (en) 2011-08-22 2015-05-29 Microlin Llc
US9295586B2 (en) 2011-08-31 2016-03-29 Kci Licensing, Inc. Absorbent polymer dressings, systems, and methods employing evaporative devices
JP6129838B2 (en) 2011-09-01 2017-05-17 エムシー10 インコーポレイテッドMc10,Inc. Electronic device that detects the condition of the tissue
EP2565630B1 (en) 2011-09-02 2015-08-19 CSEM Centre Suisse D'electronique Et De Microtechnique SA Dye-doped gelatin-coated optical fibers for in situ monitoring of protease activity in wounds
EP2753718A4 (en) 2011-09-08 2015-12-30 Indicator Systems International Inc Infection activated wound caring compositions and devices
JP6169082B2 (en) 2011-09-24 2017-07-26 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Artificial skin and elastic strain sensor
WO2013049716A1 (en) 2011-09-28 2013-04-04 Mc10, Inc. Electronics for detection of a property of a surface
WO2013066775A1 (en) 2011-10-31 2013-05-10 Smith & Nephew, Inc. Apparatuses and methods for detecting leaks in a negative pressure wound therapy system
US9393354B2 (en) 2011-11-01 2016-07-19 J&M Shuler Medical, Inc. Mechanical wound therapy for sub-atmospheric wound care system
CA2850958C (en) 2011-11-11 2020-07-14 Kci Licensing, Inc. Dressings and systems for treating a wound on a patients limb employing liquid control
US10004643B2 (en) 2011-12-07 2018-06-26 Kci Licensing, Inc. Synthetic granulating gauze for use with reduced-pressure treatment systems
US9569566B2 (en) 2011-12-12 2017-02-14 Zam Research Llc Simulation and control system and method using contact, pressure waves and factor controls for cell regeneration, tissue closure and related applications
US9603560B2 (en) 2012-01-26 2017-03-28 The University Of Akron Flexible electrode for detecting changes in temperature, humidity, and sodium ion concentration in sweat
WO2016109744A1 (en) 2014-12-31 2016-07-07 Sensoria Inc. Sensors, interfaces and sensor systems for data collection and integrated monitoring of conditions at or near body surfaces
JP6272238B2 (en) 2012-01-30 2018-01-31 センソリア・インコーポレイテッド Sensors, interfaces and sensor systems for integrated remote monitoring and data collection of conditions at or near the body surface
FR2986151B1 (en) 2012-01-30 2014-03-14 Commissariat Energie Atomique DRESSING HAVING A DETECTION SYSTEM.
WO2013116013A1 (en) 2012-02-02 2013-08-08 The United States Government, As Represented By The Department Of Veterans Affairs Integrated surface stimulation device for pain management and wound therapy
US9282897B2 (en) 2012-02-13 2016-03-15 MedHab, LLC Belt-mounted movement sensor system
US10046096B2 (en) 2012-03-12 2018-08-14 Smith & Nephew Plc Reduced pressure apparatus and methods
CN105283122B (en) 2012-03-30 2020-02-18 伊利诺伊大学评议会 Appendage mountable electronic device conformable to a surface
US8887313B2 (en) 2012-03-30 2014-11-18 Aaron McGuin Wrap for human appendage
US10158928B2 (en) 2012-04-12 2018-12-18 Elwha Llc Appurtenances for reporting information regarding wound dressings
US9084530B2 (en) 2012-04-12 2015-07-21 Elwha Llc Computational methods and systems for reporting information regarding appurtenances to wound dressings
US10265219B2 (en) 2012-04-12 2019-04-23 Elwha Llc Wound dressing monitoring systems including appurtenances for wound dressings
US10130518B2 (en) 2012-04-12 2018-11-20 Elwha Llc Appurtenances including sensors for reporting information regarding wound dressings
EP2836177A4 (en) 2012-04-12 2016-04-06 Elwha Llc Appurtenances for reporting information regarding wound dressings
US9332918B1 (en) 2012-05-07 2016-05-10 Jill Buckley Patient monitoring devices and systems
WO2013175310A2 (en) 2012-05-22 2013-11-28 Smith & Nephew Plc Apparatuses and methods for wound therapy
US9226402B2 (en) 2012-06-11 2015-12-29 Mc10, Inc. Strain isolation structures for stretchable electronics
US9582072B2 (en) 2013-09-17 2017-02-28 Medibotics Llc Motion recognition clothing [TM] with flexible electromagnetic, light, or sonic energy pathways
DE102012211015A1 (en) 2012-06-27 2014-01-02 Robert Bosch Gmbh Wound dressing device has wound-contact region, wound analysis region, cover layer region and evaluation unit, where wound analysis region is arranged between wound-contact region and cover layer region
EP2866851B1 (en) 2012-06-28 2019-09-11 KCI Licensing, Inc. Wound connection pad with rfid and integrated strain gauge pressure sensor
US9814401B2 (en) 2012-07-06 2017-11-14 Covidien Lp Angiosome-based perfusion monitoring system
EP2872877B1 (en) 2012-07-10 2023-05-24 The General Hospital Corporation System and method for monitoring and treating a surface of a subject
US20140018637A1 (en) 2012-07-12 2014-01-16 Oakwell - Cayman Company Cloud-Based Monitoring of Medical Devices
EP2886050B1 (en) 2012-08-14 2017-01-04 Terumo Kabushiki Kaisha Body water meter
KR20140024743A (en) 2012-08-21 2014-03-03 삼성전기주식회사 Jig for manufacturing touch panel
KR101224629B1 (en) 2012-09-05 2013-01-22 주식회사 뉴피아 Dermal patch using light
AT513325B1 (en) 2012-09-06 2014-09-15 Ima Integrated Microsystems Austria Gmbh Method and device for monitoring wound healing
US9811901B2 (en) 2012-09-07 2017-11-07 Massachusetts Institute Of Technology Linear-based Eulerian motion modulation
US8948839B1 (en) 2013-08-06 2015-02-03 L.I.F.E. Corporation S.A. Compression garments having stretchable and conductive ink
US8997588B2 (en) 2012-09-29 2015-04-07 Stryker Corporation Force detecting mat with multiple sensor types
US20140107495A1 (en) 2012-10-17 2014-04-17 Nokia Corporation Wearable Apparatus and Associated Methods
US20140107498A1 (en) 2012-10-17 2014-04-17 Nokia Corporation Wearable Apparatus and Associated Methods
WO2014066300A1 (en) 2012-10-27 2014-05-01 President And Fellows Of Harvard College Multi-axis force sensing soft artificial skin
KR101402925B1 (en) 2012-11-06 2014-06-02 주식회사 오라컴 Vaccum Zig System For Flexible Printed Circuit Board
US9968488B2 (en) 2012-11-12 2018-05-15 Kci Usa, Inc. Externally-applied patient interface system and method
EP2919648A1 (en) 2012-11-16 2015-09-23 Indicator Systems International, Inc. Electrochemical determination of infection
US20140147611A1 (en) 2012-11-23 2014-05-29 Sure Flash Llc Conformable Preconditioned Adhesive Sealing Tape
EP2941195B1 (en) 2013-01-02 2016-12-07 FibroTx OÜ Device to measure analytes in the skin
KR20150110570A (en) 2013-01-08 2015-10-02 엠씨10, 인크 Application for monitoring a property of a surface
GB201317742D0 (en) 2013-10-08 2013-11-20 Smith & Nephew Ph indicator dressing
GB201401112D0 (en) 2014-01-23 2014-03-12 Smith & Nephew Systems and methods for wound monitoring
GB201317746D0 (en) 2013-10-08 2013-11-20 Smith & Nephew PH indicator
GB201300470D0 (en) 2013-01-11 2013-02-27 Smith & Nephew Moisture indicator dressing
GB201309369D0 (en) 2013-05-24 2013-07-10 Smith & Nephew Moisture indicating system
US10583037B2 (en) 2013-01-23 2020-03-10 Transqtronics, Llc. Heating device using exothermic chemical reaction
AU2014212124A1 (en) 2013-02-01 2015-09-10 Daniel FARKAS Method and system for characterizing tissue in three dimensions using multimode optical measurements
US9613911B2 (en) 2013-02-06 2017-04-04 The Board Of Trustees Of The University Of Illinois Self-similar and fractal design for stretchable electronics
US9026053B2 (en) 2013-02-17 2015-05-05 Fitbit, Inc. System and method for wireless device pairing
US20140243709A1 (en) 2013-02-28 2014-08-28 Hill-Rom Services, Inc. Pressure Sensing Pad, Method of Making the Same, Pressure Sensing System, and Pressure Map Display
US9042075B2 (en) 2013-03-04 2015-05-26 Nokia Technologies Oy Apparatus and method for water protection of an electronic device
US20160022223A1 (en) 2013-03-13 2016-01-28 The Regents Of The University Of California Multi-modal depth-resolved tissue status monitor
US11433254B2 (en) 2013-03-15 2022-09-06 Pavel V. Efremkin Apparatus and method for treatment of wounds and skin medical conditions at a predetermined skin area
US9398880B2 (en) 2013-03-20 2016-07-26 Kelly Annette Vanscoy Barnett Plurality of lamination for soft tissue compression support, protection and bracing; intelligent textile for equine and equestrian sports or activities
WO2014160764A1 (en) 2013-03-26 2014-10-02 Carolon Comapny Body monitoring system
US9494474B2 (en) 2013-04-03 2016-11-15 Texavie Technologies Inc. Core-shell nanofiber textiles for strain sensing, and methods of their manufacture
WO2014172248A1 (en) 2013-04-16 2014-10-23 Drexel University Radial compression utilizing a shape-memory alloy
CA2911085C (en) 2013-05-02 2017-07-18 Vomaris Innovations, Inc. Expandable wound dressings
US9706647B2 (en) 2013-05-14 2017-07-11 Mc10, Inc. Conformal electronics including nested serpentine interconnects
US10314506B2 (en) 2013-05-15 2019-06-11 Polar Electro Oy Heart activity sensor structure
US10166402B2 (en) 2013-05-16 2019-01-01 Excelitas Technologies Corp. Visible light photo-disinfection patch
JP6420321B2 (en) 2013-05-21 2018-11-07 オーピクス・メディカル・テクノロジーズ・インコーポレイテッド Pressure data acquisition assembly
US10206604B2 (en) 2013-05-23 2019-02-19 Cutosense Oy Arrangement for facilitating wound healing, a method for measuring wound healing and a wound dressing
WO2014188070A1 (en) 2013-05-23 2014-11-27 Åbo Akademi University An arrangement for facilitating wound healing, a method for measuring wound healing and a wound dressing
CN104904283A (en) 2013-05-31 2015-09-09 东莞宇龙通信科技有限公司 Mobile terminal, wearable device, and equipment pairing method
US20150335288A1 (en) 2013-06-06 2015-11-26 Tricord Holdings, Llc Modular physiologic monitoring systems, kits, and methods
US10182757B2 (en) 2013-07-22 2019-01-22 The Rockefeller University System and method for optical detection of skin disease
EP3030873A4 (en) 2013-08-05 2017-07-05 Mc10, Inc. Flexible temperature sensor including conformable electronics
DE102013013013A1 (en) 2013-08-06 2015-02-12 Daniel Scharfen Device and method of a signaling channel based on vibration transmission for pairing wireless devices
AU2014329510A1 (en) 2013-10-02 2016-04-21 The Board Of Trustees Of The University Of Illinois Organ mounted electronics
JP2016532468A (en) 2013-10-07 2016-10-20 エムシー10 インコーポレイテッドMc10,Inc. Conformal sensor system for detection and analysis
GB2519987B (en) 2013-11-04 2021-03-03 Imperial College Innovations Ltd Biomechanical activity monitoring
US9418279B2 (en) 2013-11-19 2016-08-16 Qualcomm Incorporated Detection of an object's varying features with a non-stationary device
KR102365120B1 (en) 2013-11-22 2022-02-18 메디데이타 솔루션즈, 인코포레이티드 Conformal sensor systems for sensing and analysis of cardiac activity
US9192531B2 (en) 2013-11-27 2015-11-24 Chuan-Shih Wu Intelligent sensing device with warning function
CA2965866A1 (en) 2013-12-05 2015-06-11 Veriskin, Inc. Skin perfusion monitoring device
US20160302729A1 (en) 2013-12-11 2016-10-20 The Board Of Regents Of The University Of Texas System Devices and methods for parameter measurement
US9867571B2 (en) 2014-01-06 2018-01-16 Interaxon Inc. Wearable apparatus for brain sensors
WO2015112095A1 (en) 2014-01-23 2015-07-30 Agency For Science, Technology And Research Smart belt for breathing and heart rate monitoring
US9301691B2 (en) 2014-02-21 2016-04-05 Covidien Lp Instrument for optically detecting tissue attributes
JP6469124B2 (en) 2014-02-27 2019-02-13 スリーエム イノベイティブ プロパティズ カンパニー Flexible sensor patch and method of using the same
WO2015138729A1 (en) 2014-03-12 2015-09-17 Zansors Llc Contact force sensor for ablation devices
AT515656B1 (en) 2014-03-17 2016-01-15 Ait Austrian Inst Technology Device for the determination of the condition of the skin of a person
US9526427B2 (en) * 2014-03-21 2016-12-27 Hypermed Imaging, Inc. Compact light sensors with symmetrical lighting
WO2015157272A1 (en) 2014-04-07 2015-10-15 North Carolina State University Electrodes and sensors having nanowires
US10973462B2 (en) 2014-05-04 2021-04-13 Scott J. Rapp Fiber optic based devices and methods for monitoring soft tissue
US9402988B2 (en) 2014-05-06 2016-08-02 West Affum Holdings Corp. Wearable medical system with stretch-cable assembly
WO2015168720A1 (en) 2014-05-07 2015-11-12 University Of South Australia Wound sensor, system and method
US20150327777A1 (en) 2014-05-14 2015-11-19 Stryker Corporation Tissue monitoring apparatus and system
US20170086519A1 (en) 2014-05-15 2017-03-30 Sensoria, Inc. Gloves with sensors for monitoring and analysis of position, pressure and movement
WO2015179322A2 (en) 2014-05-19 2015-11-26 The Regents Of The University Of California Fetal health monitor
DE112015002436T5 (en) 2014-05-23 2017-04-06 Samsung Electronics Co., Ltd. Custom portable system having a modular sensor platform
US11026847B2 (en) 2014-06-02 2021-06-08 Zdzislaw Harry Piotrowski Systems and methods for wound healing
WO2015195720A1 (en) 2014-06-16 2015-12-23 The Regents Of The University Of California Methods and apparatus for monitoring wound healing using impedance spectroscopy
US20150359485A1 (en) 2014-06-17 2015-12-17 MAD Apparel, Inc. Biometric signal conduction system and method of manufacture
AU2015277218B2 (en) 2014-06-18 2021-02-25 Innopix, Inc. Spectral imaging system for remote and noninvasive detection of target substances using spectral filter arrays and image capture arrays
US20160015962A1 (en) 2014-07-16 2016-01-21 Mehdi Shokoueinejad Maragheh Smart Patch For Wound Management
US10383550B2 (en) 2014-07-17 2019-08-20 Elwha Llc Monitoring body movement or condition according to motion regimen with conformal electronics
US10152789B2 (en) 2014-07-25 2018-12-11 Covidien Lp Augmented surgical reality environment
US10758133B2 (en) 2014-08-07 2020-09-01 Apple Inc. Motion artifact removal by time domain projection
WO2016023027A1 (en) 2014-08-08 2016-02-11 Orn, Inc. Garment including integrated sensor components and feedback components
CN106999060A (en) 2014-08-11 2017-08-01 伊利诺伊大学评议会 For analysis temperature characteristic and the epidermis device of hot transmission characteristic
US20160051147A1 (en) 2014-08-21 2016-02-25 Irmed System and method for noninvasive analysis of subcutaneous tissue
WO2016030752A1 (en) 2014-08-25 2016-03-03 Bainisha Cvba Elastic sensor
US11219413B2 (en) 2014-08-26 2022-01-11 Dexcom, Inc. Systems and methods for securing a continuous analyte sensor to a host
US9993203B2 (en) 2014-09-05 2018-06-12 VivaLnk, Inc. Electronic stickers with modular structures
US9572507B2 (en) 2014-09-10 2017-02-21 Dymedix Corporation Combination physiologic sensor
US10258267B2 (en) 2014-09-22 2019-04-16 Capsule Technologies, Inc. Pulse oximeter with an accelerometer
WO2016057633A1 (en) 2014-10-08 2016-04-14 Revealix, Inc. Automated systems and methods for skin assessment and early detection of a latent pathogenic bio-signal anomaly
CN106793977A (en) 2014-10-17 2017-05-31 安德曼有限公司 Improvement to position feedback device
US20160317057A1 (en) 2014-10-22 2016-11-03 VivaLnk, Inc. Compliant wearable patch capable of measuring electrical signals
WO2016073777A1 (en) 2014-11-05 2016-05-12 The Regents Of The University Of California Telemedical wearable sensing system for management of chronic venous disorders
US10245614B2 (en) 2014-11-11 2019-04-02 The Regents Of The University Of California Imprinter for conformal coating of three-dimensional surfaces
US10512420B2 (en) 2014-11-21 2019-12-24 Elwha Llc Systems to monitor body portions for injury after impact
CN106999131A (en) 2014-11-27 2017-08-01 皇家飞利浦有限公司 Imaging device and method for the image that generates patient
US9380698B1 (en) 2014-12-05 2016-06-28 VivaLnk, Inc. Stretchable electronic patch having a foldable circuit layer
US9378450B1 (en) 2014-12-05 2016-06-28 Vivalnk, Inc Stretchable electronic patch having a circuit layer undulating in the thickness direction
US20160157779A1 (en) 2014-12-08 2016-06-09 Intel Corporation Wearable sensor apparatus with multiple flexible substrates
US9483726B2 (en) 2014-12-10 2016-11-01 VivaLnk Inc. Three dimensional electronic patch
KR101709344B1 (en) 2014-12-11 2017-03-08 한국과학기술원 Paper substrare and method of preparing the same, sensor using paper substrare and method of preparing the same
US10631401B2 (en) 2014-12-15 2020-04-21 Robert Bosch Gmbh Modular deformable platform
EP3034054B1 (en) 2014-12-16 2021-01-20 Absorbest AB Wound dressing with a sensor and method for manufacturing the same
EP3240588B1 (en) 2014-12-29 2020-02-12 Smith & Nephew plc Negative pressure wound therapy apparatus and method of operating the apparatus
US10695555B2 (en) 2015-01-08 2020-06-30 Ecole Polytechnique Federale De Lausanne (Epfl) Synthetic skin for recording and modulating physiological activities
AU2016200113B2 (en) 2015-01-21 2019-10-31 Covidien Lp Wirelessly detectable objects for use in medical procedures and methods of making same
US10039466B2 (en) 2015-01-28 2018-08-07 City University Of Hong Kong Apparatus for detection of electrical signals of a biological subject and electrode thereof, and method of manufacture thereof
US20160228049A1 (en) 2015-02-06 2016-08-11 Nxp B.V. Wound monitoring
KR102350499B1 (en) 2015-02-17 2022-01-14 삼성전자주식회사 Electromagnetic shield structure for electronic device
US10022073B2 (en) 2015-03-20 2018-07-17 Intel Corproation Wearable apparatus with a stretch sensor
US10485481B2 (en) 2015-03-20 2019-11-26 The Trustees Of Dartmouth College Systems and methods for enhancing uptake of therapeutic agent from bloodstream into disease site
WO2016154507A1 (en) 2015-03-25 2016-09-29 Son Jae S Apparatuses, devices, and methods for measuring fluid pressure variation in an insole
WO2016166731A1 (en) 2015-04-15 2016-10-20 King Abdullah University Of Science And Technology Wound dressing with reusable electronics for wireless monitoring
US10182740B2 (en) 2015-04-24 2019-01-22 Bruin Biometrics, Llc Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements
CA2980511A1 (en) 2015-04-27 2016-11-03 Smith & Nephew Plc Reduced pressure apparatuses and methods
KR101572119B1 (en) 2015-04-30 2015-11-26 주식회사 오라컴 Vaccum Zig For FPCB
US20160331263A1 (en) 2015-05-13 2016-11-17 Ep Solutions Sa Customizable Electrophysiological Mapping Electrode Patch Systems, Devices, Components and Methods
WO2016187136A1 (en) 2015-05-15 2016-11-24 Veriskin, Inc. Cutaneous blood flow monitoring device
US20160338591A1 (en) 2015-05-21 2016-11-24 Hill-Rom Services, Inc. Systems and methods for mitigating tissue breakdown
WO2016205465A1 (en) 2015-06-16 2016-12-22 Sridhar Iyengar Apparatuses, devices, and methods for measuring insole deformation
WO2016205881A1 (en) 2015-06-23 2016-12-29 Ti2 Medical Pty Ltd Anisotropically conductive material for use with a biological surface
AU2016282079A1 (en) 2015-06-26 2017-12-14 Impedimed Limited Impedance methods and apparatuses using arrays of bipolar electrodes
US20170007853A1 (en) 2015-07-10 2017-01-12 Medtronic, Inc. Physiological monitoring for ultrasound therapy
JP6590928B2 (en) 2015-07-15 2019-10-16 オリンパス株式会社 Image processing apparatus, imaging system, image processing method, and image processing program
EP3117807A1 (en) 2015-07-16 2017-01-18 Carag AG Multifunctional wound treatment dressing
DE102015010189A1 (en) 2015-08-04 2017-02-09 Infineon Technologies Ag Body parameter monitoring device
WO2017021965A2 (en) 2015-08-06 2017-02-09 Upright Technologies Ltd. Body movement feedback system and method
WO2017034257A1 (en) 2015-08-21 2017-03-02 주식회사 아모그린텍 Wearable flexible printed circuit board, manufacturing method therefor and wearable smart device using same
EP3340860A1 (en) 2015-08-24 2018-07-04 L.I.F.E. Corporation S.A. Physiological monitoring garments with enhanced sensor stabilization
MX2018001293A (en) 2015-08-26 2018-05-17 Kimberly Clark Co Hand held devices for magnetic induction tomography.
WO2017041014A1 (en) 2015-09-02 2017-03-09 The General Hospital Corporation Electroencephalogram monitoring system and method of use of the same
EP3344125A1 (en) 2015-09-04 2018-07-11 Footfalls And Heartbeats (UK) Limited Combined textile pressure and optic sensor
CN105250075A (en) 2015-09-12 2016-01-20 深圳市前海安测信息技术有限公司 Wound healing degree monitoring system and method
CN105105716A (en) 2015-09-12 2015-12-02 深圳市前海安测信息技术有限公司 Intelligent sensor used for detecting healing degree of wound and manufacturing method thereof
CN105250074A (en) 2015-09-12 2016-01-20 深圳市前海安测信息技术有限公司 Wound infection degree monitoring system and method
KR102556007B1 (en) 2015-10-07 2023-07-17 삼성전자주식회사 Apparatus and method for measuring bio signal
CN105232229B (en) 2015-10-19 2018-07-24 中国人民解放军第四军医大学 A kind of intelligent radio sensing dressing that can monitor wound healing in real time
US9484209B1 (en) 2015-11-20 2016-11-01 International Business Machines Corporation Flexible and stretchable sensors formed by patterned spalling
CN105395184B (en) * 2015-12-04 2018-05-08 华中科技大学 The multi-parameter detecting method and device of biological tissue's blood flow, blood oxygen and blood volume
US20170156594A1 (en) 2015-12-07 2017-06-08 Bodymedia, Inc. Systems, methods, and devices to determine and predict physilogical states of individuals and to administer therapy, reports, notifications, and the like therefor
US11478178B2 (en) 2015-12-08 2022-10-25 Carnegie Mellon University Electronic structures on swollen hydrogels
US11141100B2 (en) 2015-12-23 2021-10-12 Coloplast A/S Moisture assessment system and method for wound care
CN108697832B (en) 2016-01-06 2022-10-11 3M创新知识产权公司 System for treating a wound with a dressing having an obturator foramen
US20170202711A1 (en) 2016-01-19 2017-07-20 Andrei Cernasov Wound treatment system and method
EP3208700B1 (en) 2016-02-05 2020-04-01 Lg Electronics Inc. Iot device, mobile terminal and method for controlling the iot device with vibration pairing
US10426396B2 (en) 2016-02-10 2019-10-01 Hill-Rom Services, Inc. Pressure ulcer detection systems and methods
CA3016484A1 (en) 2016-03-07 2017-09-14 Smith & Nephew Plc Wound treatment apparatuses and methods with negative pressure source integrated into wound dressing
AU2017232548B2 (en) 2016-03-14 2022-02-17 Smith & Nephew Plc Wound dressing apparatus with flexible display
EP3231478A1 (en) 2016-04-13 2017-10-18 Oncotherm Kft. Radiofrequency hyperthermia device with double impedance matching system
CN109121396B (en) 2016-04-26 2022-04-05 史密夫及内修公开有限公司 Wound dressing and method for use with an integrated negative pressure source having a fluid intrusion inhibiting feature
EP3454809B8 (en) 2016-05-10 2020-12-30 3M Innovative Properties Company Flexible means for determining the extent of debridement required to remove non-viable tissue
CA3023772A1 (en) 2016-05-13 2017-11-16 Smith & Nephew Plc Sensor enabled wound monitoring and therapy apparatus
WO2017205728A1 (en) 2016-05-26 2017-11-30 Wound Care And Rehab Medicine Llc Pressure and vacuum sensors, systems, and associated methods
EP3463053A1 (en) 2016-06-06 2019-04-10 University of Massachusetts Systems and methods for prevention of pressure ulcers
US20170367644A1 (en) 2016-06-27 2017-12-28 Claris Healthcare Inc. Apparatus and Method for Monitoring Rehabilitation from Joint Surgery
US11883128B2 (en) 2016-08-24 2024-01-30 Mimosa Diagnostics Inc. Multispectral mobile tissue assessment
US20180056087A1 (en) 2016-08-26 2018-03-01 Adolfo Ribeiro Wearable Micro-LED Healing Bandage
US10426672B2 (en) 2016-08-26 2019-10-01 Vener8 Technologies Moisture detection and notification system
US10122184B2 (en) 2016-09-15 2018-11-06 Blackberry Limited Application of modulated vibrations in docking scenarios
CA3038282A1 (en) 2016-09-29 2018-04-05 Smith & Nephew Plc Protection of electronics in negative pressure wound therapy systems
EP3519001A1 (en) 2016-09-30 2019-08-07 Smith & Nephew PLC Negative pressure wound treatment apparatuses and methods with integrated electronics
WO2018064569A1 (en) 2016-09-30 2018-04-05 The Regents Of The University Of California Multi-modal depth-resolved tissue status and contact pressure monitor
CN108024011B (en) 2016-11-04 2020-07-31 宏达国际电子股份有限公司 Method for establishing wireless connection by vibration, electronic device, and recording medium
EP3558184A1 (en) 2016-12-22 2019-10-30 Fleming Medical Ltd. A dressing system
MX2019004923A (en) 2017-02-03 2019-06-20 Bruin Biometrics Llc Measurement of susceptibility to diabetic foot ulcers.
PT3515296T (en) 2017-02-03 2023-12-18 Bbi Medical Innovations Llc Measurement of tissue viability
WO2018144943A1 (en) 2017-02-03 2018-08-09 Bruin Biometrics, Llc Measurement of edema
PT3515297T (en) 2017-02-03 2022-09-22 Bruin Biometrics Llc Bisymmetric comparison of sub-epidermal moisture values
US10638944B2 (en) 2017-02-22 2020-05-05 Covidien Lp Methods of determining tissue viability
GB201703769D0 (en) 2017-03-09 2017-04-26 Smith & Nephew Imaging apparatus and method of imaging
EP3592219B1 (en) 2017-03-09 2023-05-10 Smith & Nephew plc Device and apparatus of determining skin perfusion pressure
EP3592212B1 (en) 2017-03-09 2024-08-07 Smith & Nephew plc Wound dressing
US11324424B2 (en) 2017-03-09 2022-05-10 Smith & Nephew Plc Apparatus and method for imaging blood in a target region of tissue
JP7113845B2 (en) 2017-04-04 2022-08-05 エフ ホフマン-ラ ロッシュ アクチェン ゲゼルシャフト wearable medical device
GB201800057D0 (en) 2018-01-03 2018-02-14 Smith & Nephew Inc Component Positioning And stress Relief For Sensor Enabled Wound Dressings
WO2018209090A1 (en) 2017-05-11 2018-11-15 Kent State University Microcirculation assessment device
US12033738B2 (en) 2017-05-15 2024-07-09 Smith & Nephew Plc Negative pressure wound therapy system using eulerian video magnification
WO2018210692A1 (en) 2017-05-15 2018-11-22 Smith & Nephew Plc Wound analysis device and method
JP2020520781A (en) 2017-05-17 2020-07-16 ユービック インダストリー パートナーシップス インコーポレイテッドUvic Industry Partnerships Inc. Wound dressing for wound monitoring and therapeutic drug delivery
EP3409190A1 (en) 2017-05-31 2018-12-05 CutoSense Oy Measuring wound healing
GB2563602B (en) 2017-06-19 2022-06-08 Middlesex Univ Higher Education Corporation Method and apparatus for imaging
EP3641627B1 (en) 2017-06-23 2023-05-31 Smith & Nephew PLC Positioning of sensors for sensor enabled wound monitoring or therapy
GB201803496D0 (en) 2018-03-05 2018-04-18 Smith & Nephew Skewing pads for impedance measurement
GB201804502D0 (en) 2018-03-21 2018-05-02 Smith & Nephew Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
GB201809007D0 (en) 2018-06-01 2018-07-18 Smith & Nephew Restriction of sensor-monitored region for sensor-enabled wound dressings
CN111093726B (en) 2017-08-10 2023-11-17 史密夫及内修公开有限公司 Sensor positioning for performing wound monitoring or treatment of sensors
US20190060126A1 (en) 2017-08-30 2019-02-28 Hill-Rom Services, Inc. Systems for monitoring wounds and wound dressing status and systems for protecting wounds
US11759144B2 (en) 2017-09-10 2023-09-19 Smith & Nephew Plc Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings
GB201718870D0 (en) 2017-11-15 2017-12-27 Smith & Nephew Inc Sensor enabled wound therapy dressings and systems
GB201804971D0 (en) 2018-03-28 2018-05-09 Smith & Nephew Electrostatic discharge protection for sensors in wound therapy
US11160491B2 (en) 2017-09-12 2021-11-02 Hill-Rom Services, Inc. Devices, systems, and methods for monitoring wounds
GB201718859D0 (en) 2017-11-15 2017-12-27 Smith & Nephew Sensor positioning for sensor enabled wound therapy dressings and systems
JP7282079B2 (en) 2017-09-27 2023-05-26 スミス アンド ネフュー ピーエルシー PH Sensing for Sensor-Enabled Negative Pressure Wound Monitoring and Therapy Devices
US11839464B2 (en) 2017-09-28 2023-12-12 Smith & Nephew, Plc Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus
WO2019067264A1 (en) 2017-09-29 2019-04-04 Kci Licensing, Inc. Dressing exhibiting low tissue ingrowth and negative-pressure treatment method
GB201718851D0 (en) 2017-11-15 2017-12-27 Smith & Nephew Flocked conformable circuit boards for sensor enabled wound therapy dressings and systems
JP7281475B2 (en) 2017-11-09 2023-05-25 11 ヘルス アンド テクノロジーズ リミテッド Stoma monitoring system and method
EP3709943B1 (en) 2017-11-15 2024-07-24 Smith & Nephew PLC Integrated sensor enabled wound monitoring and/or therapy dressings and systems
CA3083644A1 (en) 2017-12-07 2019-06-13 Bruin Biometrics, Llc Sem trend analysis
US10080524B1 (en) 2017-12-08 2018-09-25 VivaLnk, Inc. Wearable thermometer patch comprising a temperature sensor array
EP3499510A1 (en) 2017-12-14 2019-06-19 Koninklijke Philips N.V. System and method for monitoring wound healing
EP3727236A1 (en) 2017-12-22 2020-10-28 Coloplast A/S Sensor assembly part and a base plate for an ostomy appliance and a method for manufacturing a sensor assembly part and a base plate
US11511033B2 (en) 2018-01-15 2022-11-29 Kci Licensing, Inc. Systems and methods for controlling negative pressure therapy with fluid instillation therapy
WO2019140441A2 (en) 2018-01-15 2019-07-18 Kci Licensing, Inc. Wound sensor and diagnostics system for wound therapy applications
WO2019140444A1 (en) 2018-01-15 2019-07-18 Kci Licensing, Inc. Systems and methods for sensing properties of wound exudates
EP3740259A1 (en) 2018-01-15 2020-11-25 3M Innovative Properties Company Systems and methods for controlling negative pressure therapy using properties of fluids from a tissue site
KR102067501B1 (en) 2018-03-06 2020-01-17 에릭스바이오(주) Antimicrobial Dressing Band Using Optical Pulse

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220143524A1 (en) * 2019-03-22 2022-05-12 Lego A/S Rechargeable Interactive Toy
US11857890B2 (en) * 2019-03-22 2024-01-02 Lego A/S Rechargeable interactive toy

Also Published As

Publication number Publication date
WO2018162732A1 (en) 2018-09-13
EP3592230A1 (en) 2020-01-15
US20200281513A1 (en) 2020-09-10
US11324424B2 (en) 2022-05-10

Similar Documents

Publication Publication Date Title
US20220330857A1 (en) Apparatus and method for imaging blood in a target region of tissue
US20200281512A1 (en) Imaging apparatus and method of imaging blood vessels in a target region of tissue
KR102506587B1 (en) Camera having light emitting device, method for imaging skin and method for detecting skin conditions using the same
JP6393440B1 (en) Compact optical sensor
US20150223749A1 (en) Skin condition evaluation apparatus and skin condition evaluation method using the same
EP2000082A1 (en) Apparatus for obtaining oxygen-saturation information and method thereof
KR20100033371A (en) Apparatus and method for recognizing subcutaneous vein pattern
US8169471B2 (en) Image capturing system, image capturing method, and computer readable medium
JP6700703B2 (en) Vein visualization device
JP2012066066A5 (en)
TW201705900A (en) Physiological detection system with adjustable signal source and operating method thereof
JP2008525158A5 (en)
CN105979852A (en) Image analysis device, image analysis method, program, and illumination device
JP2012130504A5 (en)
RU2016144349A (en) INTELLECTUAL NOZZLE ON A SMARTPHONE TO DETERMINE THE CLEANITY, HUMIDITY AND PHOTO AGE OF THE SKIN
US20210201496A1 (en) Device, system and method for image segmentation of an image of a scene including a subject
WO2019185375A1 (en) Device, system and method for determining at least one vital sign of a subject
JP2022183277A (en) Endoscope device, endoscope processor, and endoscope device operation method
JP2012147279A (en) Near-infrared imaging apparatus
JP2012125402A5 (en) Endoscope system, processor device for endoscope system, and method for operating endoscope system
US11464453B2 (en) Cellphone based tissue oxygenation measuring device
US20190076005A1 (en) Fluorescent imaging device for plaque monitoring and multi-imaging system using same
JP2017104664A5 (en)
JP6476610B2 (en) Dermoscopy imaging apparatus, control method therefor, and program
US20150196240A1 (en) Non-invasive living body measurement device

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION